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Abstract 
Regulation of the Centromeric Histone H3 variant Cse4 by the E3 
Ubiquitin Ligase, Pshl 
Prerana Ranjitkar 
Chair of the Supervisory Committee: 
Professor, Sue Biggins 
Division of Basic Sciences, FHCRC 
Aneuploidy, one of the most common hallmarks of cancer, results from defects 
in chromosome segregation during cell division. Once cells replicate their genome, 
sister chromatids must be accurately segregated into daughter cells during mitosis in 
order to ensure genomic stability. 
Chromosome segregation IS directed by the kinetochore, a multi-protein 
complex that assembles onto specialized chromosomal locus called the centromere. 
Because centromere DNA is not conserved, there are epigenetic mechanisms that ensure 
its propagation. Cenp-A, a conserved histone H3 variant appears to be the epigenetic 
mark that specifies centromere identity and is essential for kinetochore assembly and 
function. Exclusive localization of Cenp-A to the centromere is critical to prevent 
formation of di-centric chromosome that can be broken during segregation. Proteolysis 
is one of the mechanisms that cells utilize to regulate Cenp-A levels and prevent its 
mislocalization to non-centromeric loci in budding yeast and flies. However, the 
molecular machinery and the underlying mechanisms are not known. In my research, I 
focused on identifYing proteins involved in degradation of Cenp-A and elucidate the 
meehanism by which the proteolytic machinery prevents eetopic localization of Cenp-A 
using budding yeast as a model system. 
Cse4 is the Cenp-A homolog in budding yeast. To identify Cse4 degradation 
machinery, I focused on known and novel Cse4 interacting proteins that were 
previously identified in the lab. Of the various candidates, I focused on Pshl, a protein 
of unknown function. Pshl contains a R1NG domain, a hallmark of all ruNG type E3 
ligases. I demonstrated that Pshl is a bonafide E3 ligase in vitro and functions to 
ubiquitinate and degrade Cse4 in vivo. Moreover, Pshl mediated degradation of Cse4 
prevents mislocalization of Cse4 to non-centromeric loci. Consistent with this, 
overexpression of Cse4 is toxic to pshl 11 cells and leads to mislocaliztion of Cse4 to the 
euchromatin. The toxicity of Cse4 overexpression is correlated with the levels of Cse4 
protein and can be partly attributed to the activation of the spindle checkpoint. 
Since Cse4 is about 60% identical to the canonical H3, I also investigated if 
Pshl is a specific E3 ligase for Cse4 and how it is able to discriminate between the two 
histones. Pshl co-purifies with Cse4 but fails to interact with histone H3. Consistent 
with a specific function of Pshl for Cse4 proteolysis, overexpression of H3 had no 
effect on the viability of pshl 11 cells. Domain swap experiments reveal the centromere 
targeting domain (CATD) in Cse4, which is absent in H3, to be the recognition motif by 
which Pshl distinguishes Cse4 from H3. In addition, this domain appears to be required 
and sufficient for Pshl mediated degradation. Taken together, my work has shown that 
the CA TD has a previously unknown role in maintaining the exclusive localization of 
Cse4 by preventing its misloealization to euchromatin via Pshl-mediated degradation. 
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CHAPTER 1: 
Introduction 
Chromosome Segregation 
Proper execution of a number of coordinated events is crucial for ensunng 
accurate segregation of chromsomes and hence the maintainence of genomic stability 
during each cell division. Defects in this process lead to cancer and various human 
diseases. Understanding the mechanism of chromosome segregation will therefore give 
insight into the molecular basis of these diseases. 
Cell division begins with the replication of the genome during S-phase. The 
duplicated sister chromatids are held together by a protein complex called cohesin. 
During mitosis, microtubules emanating from opposite poles of the cell make attachments 
to the sister chromatids via the kinetochore, a large protein complex that assembles onto 
the centromere (Fig 1.1 and 1.2) During metaphase, tension across bioriented 
chromosomes is generated by the pulling forces of the microtubules that are opposed by 
the linkage between the sister chromatids. In the event that there is even a single pair of 
sister chromatids that have improper attachments, cells activate the spindle checkpoint, 
which halts the metaphase to anaphase transition, allowing for correction of these errors. 
Once all the sister kinetochores have achieved biorientation during metaphase, the 
spindle checkpoint is satisfied and cohesin is released allowing microtubules to pull the 
sister chromatids to opposite poles, resulting in two daughter cells, each containing the 
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correct complement of the genetic material (Fig 1.1) (for reviews, see (Bouck et aI., 2008; 
Cheeseman and Desai, 2008; Santaguida and Musacchio, 2009)). 
The Centromeric Chromatin and the kinetochore 
The centromere is the specialized chromosomal locus onto which the kinetochore 
IS assembled. Therefore, centromere function is essential for proper chromosome 
segregation and thus for genomic stability. Despite this essential and highly conserved 
function of the centromere, the sequence composition and size of the centromere are 
poorly conserved throughout the eukaryotes. The budding yeast S. cerevisiae contains a 
defined centromere sequence of ~ 125bps, which constitutes three DNA elements tenned 
CDEI, CDEII and CDEIII, that are conserved across all chromosomes. In contrast, the 
fission yeast S. pombe centromere contains a non-repetitive central core, flanked by 
inverted repeat regions while centromeres in metazoans such as D. melanogaster and H 
sapiens are composed of highly repetitive DNA sequences that lack sequence specificity 
(Verdaasdonk and Bloom, 2011). Because centromeric DNA is not conserved, there are 
epigenetic mechanisms that ensure its propagation. A hallmark of all eukaryotic 
centromere is the presence of the histone H3 variant CENP-A. 
The fundamental unit of the chromatin is the nucleosome, which contains two 
copies of each histones H2A, H2B, H3 and H4 wrapped around DNA. While the bulk 
chromatin is packaged into these canonical nuc1eosomes, at the centromeric nuc1eosome, 
histone H3 is replaced by its variant called CENP-A. The presence of CENP-A at the 
centromere is absolutely essential for kinetochore fonnation and this function cannot be 
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replaced by the canonical H3. 
The kinetochore is the macromolecular structure that is essential to direct 
chromosome segregation. The best-characterzied kinetochore is the budding yeast 
kinetochore, which comprises greater than 65 constitutive components, many of which 
are highly conserved. These components are found in biochemically distinct complexes 
and are divided into the inner, central and outer domains. The centromeric histone H3 
variant Cse4, DNA binding proteins Mif2 and Cbfl and the CBF3 complex together 
comprises the inner kinetochore. The CBF3 complex binds directly to the centromeric 
DNA and is required for the localization of an other kinetochore proteins including Cse4. 
The central kinetochore includes the MTW1 and the CTF19/COMA complexes. Finally, 
the NDC80 and DAMlIDDD/DASH complex constitutes the outer kinetochore where 
microtubule attachments are made. These proteins are conserved across species and serve 
similar function in higher organisms as well (Fig 1.2) 
Centromeric histone H3 variant, CENP-A 
All centromeres are characterized by the presence of the essential histone H3 
variant CENP-A, which localizes exclusively to the centromere (Earnshaw and Rothfield, 
1985); (Palmer et al., 1987). Because it is present at all active centromeres, it is an 
excellent candidate to epigenetically specify centromere identity (Amor and Choo, 2002; 
Warburton et al., 1997). In most organisms, centromeres contain arrays of CENP-A 
nucleosomes interspersed with histone H3 nucleosomes. In contrast, a single CENP-A 
nucleosome exists at the budding yeast centromere, consistent with a single microtubule 
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binding site (Furuyama and Biggins, 2007a; Winey et aI., 1995). 
The centromeric histone H3 variant CENP-A is highly conserved throughout 
eukaryotes. CENP-As contain a unique N-terminal tail and a conserved histone fold 
domain. The homology between H3 and its variant CENP-A is limited to this histone fold 
domain, which also contains residues that are important for targeting of CENP-A to the 
centromere. Loop 1 and a2 helix of CENP-A comprises the centromere targeting domain 
(CATD) which is necessary and sufficient to target an H3 chimera to the centromere 
(Black et aI., 2004; Vermaak et aI., 2002b) (Black et aL, 2007). This domain also binds to 
the chaperones Scm3 in budding yeast (Shivaraju et aI., 2011; Zhou et aI., 2011) and 
HJURP in humans, which are required for CENP-A deposition at the centromere, 
suggesting a potential mechanism to explain the role of the CATD in CENP-A 
localization (Dunleavy et aI., 2009; Foltz et aI., 2009). In addition to the CA TD, a whole 
host of other proteins have been shown to be important for CENP-A loading in various 
organisms. For instance in humans, CENP-A incorporation is thought to occur in a step-
wise fashion, starting with the licensing of the centromere by the recruitment of Mis 18 
complex, CENP-H, CENP-I, RbAp46/48 , followed by recruitment of loading factors 
KNL2 and HmRP that loads new CENP-A and finally proper spacing between CENP-A 
nuc1eosomes is maintained by remodeling factors such as the RSF complex (for review 
see (Verdaasdonk and Bloom, 2011)). 
CENP-A is highly enriched at functional centromeres, but it can also be 
incorporated into the euchromatin. Low levels of endogenous CENP-A can be detected in 
highly transcribed euchromatic regions of the yeast genome (Camahort et aI., 2009; 
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Lefrancois et aI., 2009) and overexpression of CENP-A leads to euchromatic localization 
in some organisms (Heun et aI., 2006b; Tomonaga et aI., 2003; Van Hooser et aI., 2001). 
In addition, CENP-A can be detected at sites of DNA double strand breaks prior to 
removal at the time of DNA repair (Zeitlin et aI., 2009). These data suggest that CENP-A 
can localize to euchromatin but is not stably maintained outside of centromeres. 
However, ectopic incorporation of CENP-A can lead to genomic instability (Amato et aI., 
2009; Au et a1., 2008; Heun et aI., 2006b») and has been shown to occur in primary 
colorectal cancer tissues (Tomonaga et aI., 2003). However, whether mistargeting of 
CENP-A to euchromatin is sufficient to assemble a kinetochore varies among eukaryotes. 
In Drosophila ectopic CENP-A is sufficient for kinetochore formation (Heun et aI., 
2006a) whereas in humans CENP-A alone is not sufficient to assemble a kinetochore 
(Van Hooser et aI., 2001) and requires the constitutive DNA-binding kinetochore 
components, CENP-C and CENP-T (Cheeseman and Desai, 2008). Taken together, these 
data suggest that there are multiple controls over both CENP-A localization and 
kinetochore formation that are critical for genomic stability. 
Insights into mechanisms that ensure exclusive centromeric localization of CENP-
A have come from studies of Cse4, the budding yeast homolog and CID, the homolog in 
flies. The levels of Cse4 are regulated by proteasome dependent ubiquitin-mediated 
proteolysis that specifically degrades the euchromatic CENP-A while the centromere-
bound CENP-A appears to be protected from degradation (Collins et aI., 2004b). CID is 
also proteolytically regulated, although whether it is also ubiquitin-mediated is not known 
(Moreno-Moreno et aI., 2006). CENP-A proteolysis has also been detected in human 
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cells undergoing senescence or infection with herpes simplex virus 1 (Lomonte et al., 
2000; Maehara et al., 2010) suggesting that CENP-A proteolysis is a conserved 
mechanism. However, the molecular machinery involved in CENP-A degradation has not 
been identified in any organism and the underlying mechanism is unclear. Similarly, how 
the centromere bound CENP-A is protected from degradation is not known. 
The Ubiqutin-Proteasome Pathway 
Ubiquitination is a multi-step process that results in conjugation of a substrate 
protein with ubiquitin monomers via an isopeptide bond between the C terminus of 
ubiquitin and typically a lysine residue of the target protein. This process starts with the 
activation of the ubiquitin monomer with an El aetivating enzyme, followed by the 
transfer of the activated ubiquitin to an E2 conjugating enzyme and finally to the target 
protein via the E3 ligase enzyme which brings the substrate and the E2 enzyme in close 
proximity enabling the transfer of the ubiquitin monomer onto the substrate protein. The 
substrate can be monoubiquitinated at multiple sites or additional ubiquitins can be 
conjugated to any of the seven lysine residues of ubiquitin to form a polyubiquitin chain. 
The number of ubiquitin monomers assembled on a single ehain dictates the fate of the 
ubiquitinated protein. Conjugation of a chain containing four or more ubiquitin 
monomers targets the substrate for degradation by the proteasome. The E3 ligase 
enzymes, which are defined by the presence of either the HECT domain or the RING 
domain, impart specificity in this enzymatic caseade by pairing the E2 enzyme and the 
target protein (for review see (Deshaies and Joazeiro, 2009). 
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Description of Dissertation 
A large number of studies have revealed how the essential histone H3 variant 
CENP-A is recruited and maintained at the centromere. However, a critical question in 
centromere biology of how CENP-A is maintained exclusively at the centromere and 
prevented from being stably incorporated into the euchromatin is not very well 
understood. 
I used the budding yeast, S. cerevisiae to address key questions about the 
mechanisms that regulate CENP-A localization and functions. Unlike higher organisms, 
budding yeast has a single CENP-A nuc1eosome at the centromere that is sufficient to 
assemble a kinetochore (Furuyama and Biggins, 2007b). However, despite this variation 
in the number of CENP-A nucleosomes at centromeres, the budding yeast homolog Cse4 
can rescue a depletion of mammalian CENP-A (ABshire and Karpen, 2008; Wieland et 
aI., 2004), suggesting functional conservation. Although budding yeast is the only 
organism with a defined centromeric DNA sequence that is sufficient to mediate 
kinetochore assembly (Fitzgerald-Hayes et aI., 1982), epigenetic components also 
contribute to yeast kinetochore assembly (Mythreye and Bloom, 2003; Tanaka et aI., 
1999), so to varying degrees all eukaryotic organisms propagate kinetochores using 
epigenetic components. Therefore, budding yeast is an excellent model system to 
elucidate mechanisms underlying CENP-A localization and hence kinetochore assembly. 
Previous work in the lab revealed that ubiquitin-mediated proteolysis specifically 
degrades euchromatin-bound but not centromere-bound Cse4 (Collins et aI., 2004a). 
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However, the molecular machinery is not known and the underlying mechanism is not 
well understood. For example, it is not known whether Cse4 that mis-incorporates into 
chromatin is directly degraded, or whether it is removed from chromatin creating a 
soluble pool that is targeted for degradation. Moreover, it is unclear how the degradation 
machinery distinguishes Cse4 from H3 nucleosomes. These questions must be addressed 
in order to understand how cells maintain a single Cse4 nucleosome at the centromere, 
yet prevent euchromatin incorporation to ensure high fidelity chromosome segregation. 
In order to identifY the molecular machinery involved in Cse4 degradation, we 
took advantage of a mutant Cse4 protein, which cannot be ubiquitinated, thus 
accumulating at higher cellular levels than its WT counterpart. This facilitated the 
identification of a large number of known and novel Cse4 interacting proteins. In chapter 
2, I present the characterization of one of the novel interactors, Pshl, as an E3 ligase 
enzyme that degrades Cse4. Pshl-mediated degradation of Cse4 appears to be important 
for preventing accumulation of Cse4 in the euchromatin, consistent with the observation 
that overexpression of Cse4 is toxic to pshl L1 cells. Interestingly, overexpression of H3 
has no effect on the viability of pshl L1 cells, leading to the hypothesis that Pshl may be 
specific to Cse4 and not H3. In chapter 3, I describe experiments showing that Pshl is an 
E3 ligase that specifically recognizes Cse4. By performing domain swap experiments, I 
was able to identifY the centromere targeting domain of Cse4 to be the recognition motif 
of Pshl through which it distinguishes Cse4 from 113. In addition, this domain also 
regulates Cse4 stability via its binding to the E3 ubiquitin ligase. I have also included 
some data that implicates FACT, a chromatin remodeling complex in the degradation of 
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Cse4 
In Appendix A, I have summarized the results that were obtained from an e-map 
screen to identifY positive and negative genetic interactors of Pshl. Because Cse4 is not 
completely stabilized in pshl L1 mutants, there must be alternate pathways of Cse4 
degradation. We predict that genes involved in this parallel pathway will display negative 
genetic interaction with pshl L1 mutants. In Appendix B, I have also included some 
interesting observations that could be followed up on for future direction. In Appendix C, 
I present some preliminary data demonstrating that Cse4 is sumoylated. 
Taken together the work presented in this dissertation sheds insight into a largely 
unexplored area in centromere biology of how cells prevent CENP-A from mis-
incorporating at non-centromeric loci and provides a molecular basis for understanding 
this question. 
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(a) (h) ( C) 
Fig 1.1. Events during chromosome segregation. 
(a) Genome replication occurs during S phase, where the replicated sister chromatids 
are held together by the cohesin complex (shown as blue circles). (b) The sister 
chromatids are pulled by microtubules emanating from opposite poles (shown in red) 
via attachment to the kinetochore (shown in orange). The pulling forces of the 
microtubules are opposed by the cohesin linkage between the sisters chromatids, 
thereby generating tension and establishing proper bipolar attachments. ( c) Once all 
pairs of sister chromatids have achieved proper attachment, cohesin is released and the 
sisters are pulled to the opposite poles. 
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Fig 1.2. Schematic representation of the Kinetochore. 
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CHAPTER 2: 
Identification of an E3 ligase that mediates Cse4 degradation and 
prevents ectopic localization of Cse4. 
Summary 
The budding yeast centromeric histone H3 variant, Cse4 is regulated by ubiquitin 
mediated proteasome proteolysis. However, the proteins that mediate Cse4 degradation, 
namely the E3 ligase and E2 conjugating enzymes, are not known. Here, I identified Pshl 
as an E3 ligase that ubiquitinates Cse4 both in vivo and in vitro and mediates its 
degradation in vivo. Pshl-mediated degradation of Cse4 appears to be important to 
prevent ectopic chromatin localization of Cse4. Consistent with this, overexpression of 
Cse4 leads to euchromatic localization resulting in decreased viability of pshl L1 cells. The 
toxicity of Cse4 overexpression is correlated with the levels of Cse4 protein and can be 
partly attributed to the activation of the spindle checkpoint. Thus, we have identified part 
of the molecular machinery responsible for regulating Cse4. 
Introduction 
A hallmark of all active centromeres is the presence of the histone H3 variant 
CENP-A that creates a specialized chromatin structure for the assembly of the 
kinetochore for directing chromosome segregation. Therefore, it is extremely critical that 
CENP-A is exclusively localized to the centromere to ensure the fidelity of chromosome 
segregation. Studies from different organisms have identified a host of proteins that are 
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important for centromeric localization of CENP-A. In budding yeast, NdclO, a 
component of the CBF3 complex that directly binds to the centromeric DNA, is required 
for localization of Cse4 (Goh and Kilmartin, 1993). In addition, recent studies have 
implicated Scm3 in the deposition and assembly of Cse4 nuc1eosomes (Camahort et aI., 
. 2007; Shivaraju et aI., 2011; Stoler et aI., 2007). Similarly, work in S. pombe has also 
shown Scm3, together with Mis16 and Mis18, to function in the assembly of CENP-A 
nuc1eosome at the centromere. In humans, the histone chaperones RbAp46/48 , the 
centromere proteins CENP-H and CENP-I, and the loading factors KNL2 and HJURP, 
are responsible for loading new CENP-A at the centromere in a multi-step process 
(Verdaasdonk and Bloom, 2011). These studies have advanced our understanding of how 
CENP-A is localized and maintained at the centromere. 
Although CENP-A is highly enriched at functional centromeres, studies have 
shown that it can also incorporate into euchromatin. Low levels of endogenous Cse4 can 
be detected in highly transcribed euchromatic regions of the yeast genome (Camahort et 
aI., 2009) (Lefrancois et aI., 2009) and overexpression of CENP-A leads to euchromatic 
localization in some organisms (Van Hooser et aI., 2001) and CENP-A can be detected at 
sites of DNA double strand breaks prior to removal at the time of DNA repair (Zeitlin et 
aI., 2009). Taken together, these data suggest that CENP-A can localize to euchromatin 
but is not stably maintained outside of the centromeres. However, the mechanisms that 
are responsible for preventing CENP-A mislocalization or removing ectopically localized 
CENP-A are not very well understod. 
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Ubiquitin-mediated proteolysis has emerged as one mechanism that regulates 
CENP-A localization in budding yeast and flies. This mechanism appears to specifically 
degrade euchromatic but not centromere-bound CENP-A (Collins et aI., 2004b). 
Although it has not been directly tested if CENP-A degradation occurs in humans, cells 
undergoing senescence or infection with herpes simplex virus 1 (Lomonte et aI., 2000; 
Maehara et aI., 2010) appear to degrade CENP-A. In addition, CENP-A levels are 
destabilized when its chaperone HJURP is down regulated (Dunleavy et aI., 2009). 
However, the key machinery involved in CENP-A destruction has not been identified in 
any organism to date. 
Ubiquitin-mediated proteolysis requires the covalent conjugation of ubiquitin 
monomers onto a substrate protein (for review, see (Deshaies and Joazeiro, 2009)). After 
El activation, ubiquitin is transferred to an E2 conjugating enzyme and subsequently 
conjugated to a substrate via an E3 ligase. The specificity of substrate recognition is 
largely dictated by the E3 ligases, consistent with the large number of predicted E3 
relative to E1 and E2 enzymes throughout eukaryotes. Budding yeast has only 1 E1 
activating enzyme, 12 known E2 conjugating enzyme and greater than 30 predicted E3 
ligases. Here, I have identified and characterized an E3 ligase that regulates the budding 
yeast Cse4. 
Result 
Pshl is an E3 ligase that mediates Cse4 ubiquitination 
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To identify proteins involved in CENP-A degradation, we purified a lysine-free 
mutant of the budding yeast Cse4 protein that is not ubiquitinated in vivo (Collins et aL, 
2004b). 3xFLAG-Cse416R was overexpressed as the sole genomic. copy and affinity 
purified by anti-FLAG immunoprecipitation. The material was eluted with FLAG 
peptide and subjected to anion exchange followed by mass spectrometry (LC-MS/MS) on 
two of the peak fractions containing Cse4. As expected (Camahort et aI., 2009; 
Westermann et aL, 2007) we detected Cse4 and histones H2A, H2B and H4, as well as 
six kinetochore proteins (Fig 2.1A). We also identified a large number of novel 
interacting proteins including Pshl (Pob3/Spt16lhistone binding protein;(Ranjitkar et aI., 
2010», a putative E3 ubiquitin ligase that was first isolated via its interaction with the 
FACT complex (Pob3/Spt16) (Krogan et at, 2002). 
Because Pshl contains a RING domain that is a hallmark of many E3 enzymes 
(Fig 2.lB, (Deshaies and 10azeiro, 2009») I tested whether it is a ubiquitin ligase. 
Recombinant GST-Pshl exhibited robust autoubiquitination activity in vitro when 
incubated with ubiquitin, ATP, El and E2 enzymes (Fig 2.2A). The activity is specific to 
Pshl because it requires the conserved catalytic cysteines C45 and C50 in the RING 
domain. I next tested whether Psh 1 could facilitate the addition of ubiquitin to the Cse4 
protein. When Cse4 octamers were incubated with Pshl in a ubiquitin reaction in vitro, 
we detected a ladder of higher molecular weight conjugates on Cse4 (Fig 2.2B). Taken 
together, these data show that Pshl is a ubiquitin ligase that can mediate Cse4 
polyubiquitination in vitro. 
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Pshl interacts with non-centromeric Cse4 
Because Pshl was identified via its interaction with an overexpressed Cse416R 
mutant protein, I tested whether it also binds to the endogenous wild-type Cse4 protein. 
In addition, I asked whether the interaction can be detected in the absence of centromere-
bound Cse4 by abolishing its centromeric localization using the ndc1 0-1 temperature 
sensitive mutant (Goh and Kilmartin, 1993). Pshl-FLAG was immunoprecipitated from 
wild-type and ndc1 0-1 mutant cells and equivalent amounts of Cse4 were detected (Fig 
2.3A). Although this does not exclude an interaction between Pshl and Cse4 at the 
centromere, it shows that Cse4 does not need to associate with centromeres for the 
proteins to interact. Cse4 localizes to some non-centromeric loci at low abundance 
(Camahort et al., 2009; Lefrancois et aI., 2009) so I tested whether Pshl and Cse4 interact 
in euchromatin. Yeast extracts were fractioned and Pshl-FLAG was immunoprecipitated 
from the soluble and chromatin fractions. Pshl and Cse4 were associated in both 
chromatin and soluble fractions, and their interaction was not altered in ndc10-1 mutant 
cells where all chromatin-bound Cse4 is euchromatic (Fig 2.3B). Taken together, these 
data show that Pshl and Cse4 can bind independently of the centromere. 
Pshl is required for Cse4 ubiquitination and degradation in vivo 
Because Pshl is an E3 ligase that associates with Cse4 and can ubiquitinate Cse4 
octamers in vitro, I asked whether it targets Cse4 for ubiquitin-mediated proteolysis in 
vivo. First, I analyzed ubiquitin conjugates on Cse4 in the presence and absence ofPshl. 
Similar to the Cse416R protein that cannot be ubiquitinated, I found that the slower-
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migrating fonns of Cse4 that were previously shown to be ubiquitin conjugates are no 
longer detectable on either overexpressed or endogenous Cse4 protein in pshl mutant 
cells (Fig 2AA, 2AB and (Collins et al., 2004b )). I therefore analyzed Cse4 stability at 
various cell cycle stages in wild-type and pshL1 cells by arresting cells in G 1-, S- and M-
phases and monitoring the endogenous Cse4 protein levels after repressing translation. 
At all cell cycle stages, Cse4 has a short half-life, which is extended when Pshl is deleted 
(Fig 2.4C). Quantification confinned that the Cse4 half-life increases in pshl L1 cells 
(data not shown), although we cannot detennine the precise change because there are 
soluble, euchromatic and centromere-bound pools of Cse4, each with unique half-lives 
(Collins et aI., 2004b). Similar to previous observations on Cse416R (Collins et aI., 2004b) 
the total levels of Cse4 eventually decrease in pshl L1 cells. The residual degradation is 
not due to the Toml-mediated histone degradation pathway (Singh et aI., 2009) (Fig 
2.4D) and it is unclear whether the mechanism is ubiquitin-dependent. 
Cse4 accumulates in euchromatin in pshl L1 cells 
Because Pshl associates with both soluble and chromatin-bound Cse4 (Fig 2.3B), 
I tested whether Pshl specifically affects one of these Cse4 pools. Although there was 
more Cse4 in the soluble fraction prepared from pshl L1 cell extracts, there was a more 
substantial increase in chromatin-associated Cse4 (Fig 2.SA). I confinned this by 
localizing Cse4 in pshl L1 cells using chromosome spreads, a technique that removes 
soluble material and allows the chromatin-bound Cse4 to be specifically visualized (Loidl 
et aI., 1998). In contrast to wild-type cells where discrete kinetochore foci are observed, 
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transient overexpression of Cse4 in pshl L1 cells results in overall euchromatic localization 
in 100% of the DAPI masses examined. When I analyzed the kinetochore protein Mtw1-
3GFP, there was a discrete signal in 95% of the cells, suggesting that the kinetochore is 
largely intact in these cells (Fig 2.5B). Taken together, these data are consistent with 
Pshl-mediated degradation preventing Cse4 from accumulating in euchromatin. 
Cse4 overexpression is toxic to pshl L1 cells 
Although pshl ~ cells have a genomic instability phenotype (Yuen et aI., 2007) 
and display a very mild sensitivity to benomyl, the cells grow well and do not exhibit 
temperature sensitivity (Fig 2.6A and 2.6B). In addition, I did not detect a delay in cell 
cycle progression in pshl mutants (Fig 2.7). I considered the possibility that cells are 
viable without Psh1 because they maintain low cellular levels of Cse4 due to additional 
sources of regulation, such as transcriptional and post-transcriptional controls that 
regulate the major histone (Osley, 1991). I therefore tested the effect of Cse4 
overexpression on pshl L1 mutant cells. A Myc-Cse4 construct had a moderate effect on 
the growth of pshl mutant cells when overexpressed (Fig 2.8A), while a FLAG-Cse4 
construct strongly inhibited growth (Fig 2.8B). The difference in growth inhibition is 
con-elated with protein expression differences between the two contructs (Fig 2.8e), and 
it is specific to Cse4 because H3 overexpression had no effect on pshl L1 cell viability (Fig 
2.8B). I further analyzed the phenotype by releasing pshl L1 mutant cells from G 1 into 
conditions that overexpress FLAG-Cse4 and found that they die within a single cell cycle 
(Fig 2.8D). 
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To determine whether the growth defect is due to altered kinetochore function, I 
analyzed cell cycle progression in wild-type and pshL1 cells overexpressing FLAO-Cse4. 
The anaphase inhibitor Pds1 cycled normally in the control wild-type and pshlLJ mutant 
cells released from 01 (Fig 2.7). However, although Pdsl cycled normally in wild-type 
cells overexpressing Cse4, there was a transient delay in Pds 1 destruction when Cse4 was 
overexpressed inpshlLJ mutant cells released from 01 (Fig 2.9). The delay was mediated 
by the spindle checkpoint because it was eliminated when the Mad2 checkpoint protein 
was deleted, suggesting that Cse4 overexpression in pshlLJ mutant cells alters 
kinetochore function. Taken together, these data suggest there is an effect on kinetochore 
function when Cse4 is overexpressed in pshlLJ cells, although the transient checkpoint 
activation is unlikely to solely account for the complete lack of viability in a single cell 
cycle. The high level of Cse4 accumulation in euchromatin in the absence of Psh1-
mediated degradation likely disrupts one or more chromatin-based processes in addition 
to altering kinetochore function. 
Discussion 
I report here the first E3 ubiquitin ligase identified for CENP-A in any organism. 
Pshl polyubiquitinates and partially mediates Cse4 degradation in vivo. In the absence of 
Pshl, Cse4 overexpression leads to euchromatic mis-incorporation and lethality. 
Pshl mediated degradation of Cse4 
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Although the endogenous Cse4 protein can be detected in euchromatin at highly 
transcribed genes, its abundance is much lower than at centromeres (Camahort et aI., 
2009; Lefrancois et aI., 2009). These data suggest that Cse4 transiently localizes to 
euchromatin but there are mechanisms that ensure it is not stably maintained. Consistent 
with this, the overexpression of Cse4 does not lead to detectable euchromatin localization 
or have growth consequences in WT cells (Collins et aI., 2004b). In contrast, Cse4 
overexpression is toxic and leads to its accumulation in euchromatin in the absence of 
Pshl. These data strongly suggest that Psh1-mediated degradation of Cse4 is a key 
mechanism that prevents Cse4 from stably incorporating into euchromatin. 
Psh1 is present in both the soluble and chromatin fractions and interacts with 
Cse4 in both fractions. The Psh1 and Cse4 interaction can also be detected in the 
chromatin in the ndclO-l mutant, suggesting that the two proteins are able to associate 
with each other in the euchromatin, independent of the centromere. Although an 
additional role for Pshl at the centromere cannot be ruled out, I did not detect any defects 
in cell cycle progression in pshlA cells. However, a recent study detected Psh1 at the 
centromere (Hewawasam et aI., 2010) although it is not yet clear what its functional role 
at the centromere is. Nevertheless, the previously detected genomic instability in pshlA 
mutant cells is just as consistent with a function in preventing ectopic Cse4 localization 
as in regulating centromere function (Collins et aI., 2007; Yuen et aI., 2007). I 
hypothesize that the cellular levels of Cse4 are kept low by additional mechanisms, such 
as transcriptional and post-transcriptional controls that regulate the major histones 
(Osley, 1991) such that Cse4 mis-incorporation in the absence ofPshl is not sufficient to 
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manifest a gross defect under normal conditions. Consistent with this, Cse4 levels are 
only partially stabilized in the absence of Pshl so additional pathways of Cse4 
degradation exist that also need to be identified in the future. 
The toxicity ofCse4 overexpression in pshlil mutants. 
My data suggest that the toxicity caused by Cse4 overexpression in pshlil mutant 
cells may be a result of mUltiple defects. The spindle checkpoint is eventually satisfied in 
these cells, yet they die within a single cell cycle. It is not possible to determine if 
ectopic kinetochores form de novo in budding yeast because they cannot be visualized 
due to the limit of resolution of the light microscope. In addition, traditional chromatin 
immunoprecipitation techniques cannot identify ectopic kinetochores unless the site of 
assembly is similar throughout the population. I favor the possibility that the toxicity is 
due to the mislocalization of one or more kinetochore proteins as well as the disruption of 
chromatin-based processes such as transcription when Cse4 accumulates in euchromatin. 
Consistent with this, it was previously shown that the relative stoichiometry of H3 and 
Cse4 is important for the proper localization of each protein (Au et al., 2008). I was not 
able to directly test this due to technical difficulty in achieving similar levels of Cse4 
expression when H3 was simultaneously overexpressed. Regardless, my data show that 
Pshl mediates Cse4 degradation and contributes to the fidelity of its cellular localization. 
Experimental Procedures 
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Strain construction and Microbial techniques 
Media and microbial techniques are as described (Rose et al., 1990; Sherman et 
a1., 1974). Yeast strains were constructed by standard genetic techniques and are listed in 
table 2.1. 
Plasmid Construction 
The pGAL-Myc-CSE4 construct used (pSB816) was previously published (Collins 
et aI., 2004b). GST-Pshl (pSB1535) was constructed by amplifying genomic PSHI 
using primers SB2248 and SB2249 with engineered BamHI and EcoR! sites and cloned 
into the same sites of the pGEX-2T vector (Pharmacia Biotech). C45S and C50S 
mutations were introduced into pSB1535 by site directed mutagenesis using primers 
SB2346 and SB2437 to create pSB1541. Construction ofpCUPI-3XFLAG-CSEl6R was 
carried out as follows: CSE416R was PCR amplified using primers SB790 and SB70 with 
HindUI and Sac!I sites engineered and cloned into pGAL, 2~t vector (pSB 17) to generate 
pGAL_CSE416R (pSB779). pSB779 was subsequently digested with XhoI and HindIII to 
insert 3X FLAG sequence and obtain pGAL-3XFLA G_CSE416R (pSB840). The pGAL 
promoter was replaced with pCUP 1 promoter by digesting pSB840 with XhoI and KpnI 
and ligating inpCUPI at the same sites to createpCUPI-3XFLAG-CSEl6R (pSBI034). 
pSB 1665 was constructed as follows: Cse4 + 500 bp downstream region was cloned into 
a pGAL vector (pSB761). pSB761 was subsequently digested with XhoI and HindIU to 
insert 3X FLAG sequence and obtainpGAL-3XFLAG-CSE4 (PSB839). pSB839 was then 
digested with Sac! and KpnI to isolate the pGAL-3XFLA G-CSE4 fragment and ligated 
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into a URA integrating vector (PSB147) at the same sites to generate pSB1665. HHTl 
was PCR amplified with SB 2771 and 2772 with SpeI and SacI sites engineered. The 
resulting fragment was digested with the above enzymes and cloned into the same sites in 
pSB209 to generate pGAL-Myc-HHTl (pSB 1704). 
Protein and Immunological techniques 
Protein purification 
Plasmids containing either GST-Pshl (pSB1535) or the GST-Pshl RING mutant 
(pSB 1541) were transformed into BL-21 cells. Protein was purified from 2 L of cells 
after inducing expression with 1 mM IPTG for 2 hrs. GST purification was carried out as 
described (Kellogg et aI., 1995; Kellogg and Murray, 1995) . 
For Cse416R purification, 500 mls of mid-log (OD600~ 0.6) cells carrying 
pCUPl-3XFLAG-CSE416R were induced with CuS04 to a final concentration of 5 11M 
for 30 minutes. Lysates were prepared in Buffer RlO.1M KCl (25 roM HEPES pH 8.0, 2 
mM MgC12, O.1mM EDTA pH 8.0, 0.5 roM EGTA pH 8.0, 0.1 % NP-40, 15% glycerol 
and 100 llli\t1 KCI) supplemented with protease inhibitors (10 Ilg/ml leupeptin, 10 Ilg/ml 
pepstatin, 10 Ilg/ml chymostatin, and 0.2 mM PMSF) and phosphatase inhibitors (1 mM 
sodium pyrophosphate, 2 mM Na-beta-glycerophosphate, 0.1 mM NA 3V04, 5 mM NaF, 
100 nM microcystin-LR). Cells were lysed with glass beads in a beater (Biospec 
Products, Inc.) for 30 seconds, three times, with 1 min on ice in between and then 
centrifuged for 90 minutes at 27,000 rpm at 4°C. The supernatant was incubated with 60 
III of M2 anti-FLAG agarose beads (Sigma) for 3 hrs at 4°C. The beads were washed 
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with buffer HlO.3 M KCI 3 times, followed by 3 more washes with buffer H/O.l M KCl. 
Proteins were eluted with 60JlI of 0.5mg/ml FLAG peptide. The eluate from the 
purification was subject to anion exchange (0.2 ml of Source Q column) with a starting 
salt gradient ofO.1M KCI and final concentration of 1M KCl. 
Mass Spectromerty (MS) 
Mass Spectrometry (MS) analysis was carried out on fractions 14 and 15 that 
contained a peakof Cse4 protein. Each ion exchange fraction was reduced, alkylated with 
iodoacetamide, and digested with trypsin as described previously(Klammer and 
MacCoss, 2006). Each peptide mixture was loaded onto a microcapillary LC column 
(75um x 25 cm) packed with C12 reversed phase chromatography material (Phenomenex, 
Jupiter 4Jl Proteo 90;\) and interfaced with an LTQ mass spectrometer (Thermo Fisher) 
using an HPLC and an autosampler (Agilent 1100) in a nanoflow configuration as 
described previously (Klammer and MacCoss, 2006). A cycle of one full-scan mass 
spectrum (400-1400 mlz) followed by five data-dependent MS/MS spectra was collected 
throughout the reversed phase gradient. 
Each MS/MS spectrum was searched against a protein sequence database 
containing the S. cerevisiae open reading frames downloaded from SGn and common 
contaminants using SEQUEST(Eng et aI., 2008). The spectra were also searched a 
second time using a decoy database. The results from the two database searches were 
then analyzed and assigned q-values and posterior error probabilities (Kall et aI., 2008a, 
b) using the post-processing algorithm Percolator (Kall et aI., 2007). An in house 
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implementation of the IDPicker algorithm (Zhang et aI., 2007) was used to filter peptide 
spectrum matches with a q-value :'S 0.001 and assemble the resulting peptides into the 
parsimonious list of protein identifications. 
Immunoprecipitation 
For immunoprecipitations, 50 ml cultures were harvested at midlog phase and 
lysates were prepared as described except that cell extracts were (Akiyoshi et aI., 
2009)prepared with glass beads in a beater (Biospec Products, Inc.) for 35 sec, three 
times, with 1 min on ice in between and then centrifuged for 30 minutes. The supernatant 
was incubated with 10 III of protein G dynabeads (Invitrogen) and either 0.5 III of 
M2anti-Flag (sigma) or 4 I!l of A-14 anti-Myc (Santa Cruz Biotechnology, Santa Cruz, 
CA) antibodies for 2 hrs at 4° C. The beads were washed four times with lysis buffer and 
the immunoprecipitates were separated by SDS-PAGE and analyzed by immunoblotting 
as described below. 
For immunoblotting, protein extracts were made and analyzed as described 
(Minshull et aI., 1996). 9EIO anti-Myc antibodies were obtained from Covance 
(Richmond, CA) and used at a 1: 10,000 dilution. Cse4 antibodies were used at 1:500 
(Collins et aI., 2004). Tubulin antibodies were obtained from Accurate Chemical and 
Scientific (Westbury, NY) and used at 1:1000. Pgkl antibodies obtained from Invitrogen 
were used at 1: 10,000. K4-Me2 H3 antibodies were obtained from Upstate Cell Signaling 
Solutions (NY, gift from Rich Gardner) and used at 1:3000. Quantitative immunoblotting 
was performed using IR Dye 800CW obtained from LI-COR (gift from Steve Hahn, 
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FHCRC). Note that due to an increase in Cse4levels in pshlL\ mutant cells and Cse416R, 
different exposures were used to detect Cse4 ubiquitin conjugates. However, conjugates 
were not detected in the psh1 mutant cells even when exposure times were increased. 
Stability assays 
F or endogenous Cse4 stability assays, cells were grown in YEPD and 
subsequently arrested with 1 f,lg/ml a-factor (G1), 0.023 g/ml hydroxyurea (S) or 15 
f,lg/ml nocodozole (M) for 3 hrs. Samples were taken for analysis after repressing protein 
synthesis with 50 Ilg/ml of cycloheximide. For all stability assays, cells were grown in 
2% raffinose media, a timepoint (-) was taken, and then cultures were induced with 2% 
galactose for 2.5 hrs at 23°C. Timepoints were taken after inhibiting transcription and 
translation by adding glucose to 2% and cycloheximide to a final concentration of 
50llg/ml respectively. Extracts were prepared and protein levels were assayed using Myc 
antibodies or quantified as described above. 
Ubiquitination Assay 
Ubiquitination assays were performed as described (Gard(Gardner et al., 2005)ner 
et a1., 2005). 15 f,ll reactions containing 0.4 f,lg ubiquitin activating enzyme (yeast Uba1), 
0.4 Ilg ubiquitin conjugating enzyme (human UbcH5a), 36 ng purified GST-Pshl (or 
C45S, C50S mutant), 2.5 f,lg ubiquitin, 2 mM Mg-ATP, 50 mM Tris-HCl (pH7.5), 2.5 
mM MgCl 2, and 0.5 mM DTT were incubated at 23°C for 30 min. Reactions were 
stopped by adding sample buffer and boiling for 3 minutes. Ubal, UbcH5a, ubiquitin and 
27 
Mg-ATP were obtained from Boston Biochemicals. Ubiquitin conjugates were detected 
using anti-ubiquitin antibodies (gift from D. Gottschling, FHCRe). Cse4 and core 
histones were produced in E. coli (Luger et aI., 1997). Histone octamers were refolded 
and purified by Superdex S-200 gel-filtration chromatography as described(Dyer et aI., 
2004). 11lg of Cse4 octamers were used in ubiquitination assays and probed for Cse4 
ubiquitin conjugates with anti-Cse4 antibodies (gift from Carl Wu, NIH). 
Chromatin Fractionation assays 
Chromatin Fractionation experiments were performed as described (Liang and 
Stillman, 1997) with the following changes. 30 Units of micrococcal nuclease 
(Worthington Biochemical Corporation) per 50 ml of mid-log culture were used to 
solubilize the chromatin. The micrococcal nuclease digestion was carried out at 37°C for 
15 minutes and analyzed after stopping the reaction with ImM EDTA. For fractionation 
followed by immunoprecipitation, the same protocol was used to prepare soluble and 
chromatin fractions and immunoprecipitations were carried out as described above. 
Immunofluorescence 
Cells were grown in lactic acid, followed by nocodazole arrest for 3hrs. For the 
last hour of arrest, FLAG-Cse4 expression was induced with 2% galactose. Chromosome 
spreads were performed as described previously (Collins et aI., 2004b). DAP! was 
obtained from Molecular Probes (Eugene, OR) and used at a lllglrnl final concentration. 
Upsol was obtained from Fisher. Anti-Cse4 antibodies were used at 1 :250 
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dilution(Collins et al., 2004b), Cy3 and Cy5 secondary antibodies from Jackson 
Immunoresearch (West Grove, PA) were used at a 1:1000 dilution, and Alexafluor-GFP 
antibodies obtained from Invitrogen were used at a 1 :250 dilution. 
Viability and Pdsl assay 
To assay viability and Pdsl levels, cells were grown in YEP + lactic acid media 
and arrested in G 1 with 1 flg/ml of (1- factor for 3.5 hrs. Cse4 overexpression was induced 
with 2% galactose during the last 30 min of the arrest and then the cells were washed and 
released into 2% galactose. (1- factor was added back when cells were small-budded to 
prevent cells from entering the second cell cycle. To assay viability, cells were plated on 
YPD at 23°C after diluting 10-4 and> 100 cells were counted for each strain. To assay 
Pds 1 levels, lysates were made as described above. 
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A 
% Unique Total 
Proteins Coverage Peptides Peptides 
Histones 
Hta1, Hta2 56.8 7 16 
Htb1, Htb2 36.6 6 7 
Hhf1, Hhf2 60.2 13 20 
Cse4 20.1 8 22 
Kinetochore 
Ame1 11.1 3 3 
Ctf19 17.9 5 5 
Mcm21 16.8 4 4 
Mif2 21.1 8 8 
Nkp1 18.9 3 3 
Okp1 17.5 6 6 
Other 
. Psh1 36.2 17 25 
B 
Fig 2.1. Psh 1 is an E3 ligase that co-purifies with Cse4. 
(A) List of histone and kinetochore proteins identified by MS after purification 
of3xFLAG-Cse416R (SBY5442). (B) Pshl has a consensus RING domain 
(residues 29-71, black) and a pair ofC4-type zinc finger motifs (residues 150-171, 
gray). RING domain cysteine and histidine residues predicted to bind zinc are in 
large typeface and the mutants are indicated in bold. "B" is a bulky residue in the 
RING domain 
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+ + + + +(/J - - + + + + +(/J Uba1 0 0 
+ - + + + +1.0 - + - + + + +1.0 - UbcH5a 0 0 
+ + - + + + - - + + - + + + - - Ub (/J (/J 
+ + + - + +~ - + + + - + +~ - ATP 
+ + + + - + 0 + + + + + - +0+ GST-Psh1 
'-__ -:-:-;-__ -J ~~,~' "~I ~.~.~~~~-GST-PSh1 
b a-GST 
B 
+ + Uba1 
+ + UbcH5a 
+ + Ub 
+ + ATP 
+ + GST-Psh1 
+ + + Cse4 oct. 
Fig 2.2. Pshl ubiquitinates Cse4 in vitro. 
(A) Pshl autoubiquitinates in vitro. Recombinant GST-Pshl was added to 
reactions in the presence (+) or absence (-) of ubiquitin-activating enzyme (Uba! ), 
ubiquitin-conjugating enzyme (UbcHSa), ubiquitin (Ub), and ATP (lanes 1-6). 
A recombinant GST-Psh1 RING mutant with C4SS and CSOS mutations was used 
in a complete reaction instead ofWT protein in lane 7. Lane 8 contains GST-Psh1 
alone. The reactions were run on two gels and immunoblotted with either anti-
ubiquitin antibody (left) or anti-GST antibody (right). (B) Recombinant Cse4 
octamers were added to reactions containing ubiquitin-activating enzyme (Uba!), 
ubiquitin-conjugating enzyme (UbcHSa), ubiquitin (Ub), andATP in the absence H 
or presence (+) of GST-Psh 1 (lanes 2 and 3). GST-Psh1 (lane 1) or Cse4 octamers 
(lane 4) alone were also included in the immunoblot as controls. The blot was 
probed with anti-Cse4 antibodies. 
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Fig 2.3. Pshl and Cse4 can associate independently of the centromere. 
(A) Wild-type (SBY8281) or ndclO-l mutant (SBY8282) cells containing Pshl-FLAG 
were shifted to 37°C for 3 hrs and Psh 1-FLAG was immunoprecipitated. The 
corresponding immunoblot was probed with anti-FLAG and anti-Cse4 antibodies. 
(B) WT (SBY8281) or ndc10-1 mutant (SBY8282) cells were grown as in (A). 
Pshl-FLAG was immunoprecipitated from the soluble (S) and chromatin (P) fractions 
and the resulting immunoblots were probed with anti-FLAG and anti-Cse4 antibodies. 
Pgkl and K4-Me2 H3 are shown as markers for Sand P fractions, respectively. Note 
that there is loss of material during the procedure so the levels between soluble and 
chromatin fractions cannot be compared. 
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A 
1t1 
Myc-Cse4 
Tubulin 
K4-Me2 H3 
B 
DAPI Mtw1-GFP Cse4 
Fig 2.5 Pshl prevents Cse4 from accumulating in euchromatin. 
Extracts (WCE) from wild-type (SBY3570) and pshl A (SBY8355) cells expressing 
pGAL-Myc-CSE4 were fractionated into soluble (S) and chromatin (P) fractions. 
Cse4levels were assayed in each fraction using anti-Myc antibodies. Tubulin and 
K4-Me2 H3 are markers for Sand P fractions, respectively. Note that there is loss 
of material during the procedure so the levels between soluble and chromatin 
fractions cannot be compared. (B) FLAG-Cse4 was transiently overexpressed for 
1 hour in wild-type (SBY8918) and pshl A (SBY8917) cells and its chromatin 
localization was assayed by immunofluorescence on chromosome spreads. DAPI, 
Alexafluor-GFP and anti-Cse4 staining recognize the DNA, Mtwl, and Cse4, 
respectively. Scale bar 5 ~m. 
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Fig 2.6. Pshl mutants do not show sensitivity to higher temperature or to benomyl. 
(A) 5-fold serial dilutions ofWT (SBY3),pshl!::. (SBY8336) and mad2!::. (SBY292) 
cells plated on glucose or benomyl plates at 23 0e. (B) 5-fold serial dilutions ofWT 
(SBY3) and pshl!::. (SBY8336) cells grown at 23°C and 37°e. 
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Fig 2.7. Psh 1 mutants have normal cell cycle progression 
WT (SBY8738) and pshl ~ (SBY8737) cells were arrested in G I in 
YEP + lactic acid media for 3.5 hrs. Cells were subsequently released into the 
cell cycle and samples were taken at the indicated timepoints. Alpha-factor was added 
back to analyze a single cell cycle. Pds I-Myc levels were analyzed using anti-Myc. 
Pgkl is shown as a loading control. 
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Fig 2.9. Spindle checkpoint is weakly activated inpshll1 cells when Cse4 
is overexpressed. Wild-type (SBY8976), pshll1 (SBY 8982) and pshll1 mad211 
(SBY8975) cells containing pGAL-FLA G-CSE4 were released from G 1 into 
galactose media. Lysates were prepared at the indicated time points and 
analyzed for Pds 1 levels by immunoblotting. 
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Table 2.1. Yeast strains used in this study. All strains are isogenic with the W303 
background. Plasmids are indicated in brackets. 
Strain Genotype 
SBY3 
SBY292 
SBY674 
SBY3570 
SBY3571 
SBY4471 
SBY5442 
SBY7268 
SBY8281 
SBY8282 
MATa ura3-11eu2,3-112 his3-11 trpl-l ade2-1 canl-IOO barl-l 
MATa ura3-lleu2,3-112 his3-11 trpl-l ade2-1 canl-IOO barl-l 
mad2::URA 
MATa ura3-1::pGAL::URA3Ieu2,3-112 his3-ll trpl-l ade2-1 
canl-IOO barl-l 
MATa ura3-11eu2,3-112 his3-11 trpl-l ade2-1 canl-IOO barl-l 
(pSB816, pGAL-13Myc-CSE4, URA3,2J.1) 
MATa ura3-lleu2,3-112 his3-11 trpl-l ade2-1 canl-IOO barl-l 
(pSB817, pGAL-13Myc-CSEi6R, URA3, 2~i) 
MATa ura3-11eu2,3-1l2 his3-11 ade2-1 canl-IOO barl-l trpl-
1::pGAL-H3::TRP I (PSB893) 
MATa ura3-lleu2,3-112 his3-11 ade2-1 canl-IOO barl-l trpl-
1::256IacO::TRPI cse4::KAN (pSBI034, pCUPI-3XFLAG-
CSE416R, URA3, 2J.1) 
MATa ura3-11eu2,3-112 his3-11 trpl-l ade2-1 canl-IOO barl-l 
PSHI-FLAG::TRPI ura3-1::pGAL-Myc-CSE4::URA3 
MATa ura3-lleu2,3-112 his3-11 trpl-l ade2-1 canl-IOO barl-l 
PSHI-FLAG::TRPI, MTWI-3GFP::HIS3 
MATa ura3-lleu2,3-112 his3-ll trpl-l ade2-1 canl-IOO barl-l 
PSHI-FLAG::TRPI ndclO-1 MTWI-3GFP::HIS3 
SBY8336 
SBY8355 
SBY8737 
SBY8738 
SBY8857 
SBY8903 
SBY8904 
SBY8917 
SBY8918 
SBY8975 
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MATa ura3-lleu2,3-112 his3-11 trpl-l ade2-l canl-lOO barl-l 
pshl::KAN 
MATa ura3-lleu2,3-l12 his3-ll trpl-l ade2-l canl-lOO barl-l 
pshl::KAN (pSB8l6, pGAL-l3Myc-CSE4, URA3, 2f-1) 
MATa ura3-lleu2,3-112 his3-11 trpl-l ade2-l canl-lOO barl-l 
pshl::KAN PDSl-Myc18::LEU2 
MATa ura3-lleu2,3-112 his3-11 trpl-l ade2-l canl-lOO barl-l 
PDSl-MycI8::LEU2 
MATa ura3-lleu2,3-112 his3-11 ade2-l canl-lOO barl-l 
pshl::KAN trpl-l::pGAL-H3::TRPl(pSB893) 
MATa leu2,3-112 his3-11 trpl-l ade2-l canl-lOO barl-l 
pshl ::KAN ura3-1 ::pGAL-FLAG-CSE4::URA(pSBl665) 
MATa leu2,3-1l2 his3-11 trpl-l ade2-l canl-lOO barl-l ura3-
1,' :pGAL-FLA G-CSE4:: URA (pSB 1665) 
MATa leu2,3-112 trpl-l ade2-1 canl-lOO barl-l his3-
Il,l5::Mtwl-3XGFP::HIS ura3-l::pGAL-FLAG-CSE4::URA3 
pshl::KAN 
MATa leu2,3-112 trpl-l ade2-l canl-lOO barl-l his3-
Il,l5::Mtwl-3XGFP::HIS ura3-l::pGAL-FLAG-CSE4::URA3 
MATa leu2,3-l12 his3-l1 trpl-l ade2-l canl-l00 barl-l 
pshl::KAN mad2::KAN PDSI-Myc18:LEU2 ura3-l::pGAL-
FLAG-CSE4::URA(pSBl665) 
SBY8976 
SBY8982 
SBY9007 
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MATa leu2,3-112 his3-11 trpl-l ade2-1 canl-100 barl-l PDS1-
Myc18:LEU2 ura3-1::pGAL-FLAG-CSE4::URA(pSB1665) 
MATa leu2,3-112 his3-11 trpl-l ade2-1 canl-100 barl-l 
pshl::KAN PDS1-Myc18:LEU2 ura3-1::pGAL-FLAG-
CSE4::URA (pSB1665) 
MATa leu2,3-112 his3-11 trpl-l ade2-1 canl-100 barl-l 
pshl ::KAN ura3-1::pGAL::URA3(pSB157) 
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Table 2.2. Plasmids used in this study 
Plasmid 
pSB157 
pSB205 
pSB209 
pSB245 
pSB816 
pSB817 
pSB893 
pSBI034 
pSB1535 
pSB1541 
pSB1665 
Description 
pGAL empty vector, URA3 (integrating) 
PDSl-18Myc, LEU2 (integrating) 
pGAL-Myc, URA3 (integrating) 
pGAL-Myc-CSE4, URA3 (integrating) 
pGAL-13Myc-CSE4, URA3, 2/A-
pGAL-13Myc-CSEi6R, URA3, 2/A-
pGAL-HHTl, TRP (integrating) 
16R pCUPl-3XFLAG-CSE4 +500 bp downstream, URA3, 2,u 
GST-PSHI in pGEX2T 
GST-PSHI C45S C50S in pGEX2T 
pGAL-FLAG-CSE4 + 500 bp downstream, URA3 (integrating) 
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CHAPTER: 3 
The centromere targeting domain of Cse4 regulates its stability and 
allows Pshl to distinguish it from H3. 
Summary 
The centromeric histone H3 variant Cse4 is regulated by proteolysis via the E3 
ubiquitn ligase Pshl. Here, I present data that shows that Pshl binds to Cse4 via the 
centromere targeting domain (CATD) and allows Pshl to discriminate between Cse4 and 
H3. Moreover, this domain regulates the stability of Cse4. Thus, the CATD appears to 
have a dual role for regulating Cse4 localization by both targeting Cse4 to the centromere 
and preventing ectopic localization of Cse4 via degradation by Psh 1. 
Introduction 
The centromeric histone H3 variant CENP-A is highly conserved throughout 
eukaryotes. All CENP-As contain a unique N-terminal tail and a conserved histone fold 
domain (HFD), which is involved in histone-histone interaction. The homology between 
H3 and its variant CENP-A is limited to this histone fold domain while the N-terminal 
tail has no sequence similarity (Stoler et at, 1995b). The histone fold domain of CENP-A 
contains residues that are important for targeting of CENP-A to the centromere. This 
domain, called the Centromere targeting domain (CATD) comprises Loop 1 and a2 helix, 
which has been demonstrated to be necessary and sufficient to target an H3 chimera to 
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the centromere (Black et aI., 2007; Vermaak et aI., 2002a). This domain also binds to the 
chaperones Scm3 in budding yeast (Shivaraju et at, 2011; Zhou et aI., 2011) and HJURP 
in humans (Foltz et aI., 2009) which are required for CENP-A deposition at the 
centromere, suggesting that this domain is required for regulating centromeric 
localization ofCENP-A. 
I found that in contrast to the overexpression of Cse4, overexpression of H3 had 
no effect on the viability of pshl L1 mutants. This led me to hypothesize that Pshl may be 
specifically regulating Cse4 and not H3. Although Pshl interacts with Cse4 both in the 
soluble and chromatin fractions, it is not yet clear whether Pshl reeognizes the soluble 
pool of Cse4 or if it recognizes ectopic Cse4 on the chromatin. Nevertheless, the ability 
of Pshl to distinguish between the two histones is important in order to ensure proper 
regulation of the two proteins. Given the high degree of homology between Cse4 and H3, 
I investigated how Pshl is able to discriminate between H3 and its variant Cse4. Here, I 
have shown that the CA TD is required for recognition of Cse4 by Psh 1. The presence of 
CATD is sufficient for Pshl to recognize a chimeric H3 and destabilize it relative to H3. 
Thus, in addition to its known function, CATD also functions to allow Pshl to 
distinguish Cse4 from H3 and regulate its stability and thereby contribute to its 
localization. 
My preliminary data also implicates the FACT complex to be involved in Pshl 
mediated degradation of Cse4. FACT (Sptl6, Pob3 and Nhp6) is a highly conserved 
chromatin remodeling complex that disassembles nucleosomes to allow passage of the 
polymerase through the chromatin during transcription and replication (Reinberg and 
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Sims, 2006; VanDemark et aI., 2006). FACT also functions as a histone chaperone to 
reassemble nucleosomes after polymerase passage. I found that Pshl mediates the 
interaction between Spt16 and Cse4 and there is a moderate effect on Cse4 stability in an 
spt16 mutant. I therefore propose that Pshl, with the help of the FACT complex, 
recognizes ectopically localized Cse4 on the chromatin and targets it for degradation. 
Results 
Pshl recognizes Cse4 but not H3. 
The lethality due to Cse4 but not H3 overexpression in pshl,1 mutant cells 
suggested that Pshl specifically interacts with Cse4. To test this, I immuno-precipitated 
Pshl-Myc from cells containing T7-H3 as the sole copy of histone lB. Although the 
endogenous Cse4 protein co-precipitated, I did not detect H3 interacting with Pshl 
despite much higher cellular protein levels (Fig 3.1A). However, Pshl was able to 
ubiquitinate H3 octamers in vitro consistent with the possibility that the E2 enzyme used 
in the reaction is promiscuous in vitro and additional factors maybe be involved in 
providing specificity in vivo (Fig 3.1B). 
Pshl recognizes Cse4 via the CArD 
I next asked how Pshl distinguishes Cse4 from H3. The Histone Fold Domains 
(HFD) ofCse4 and H3 share 64% identity, whereas theirN-terminal domains (NTD) bear 
no sequence similarity (Stoler et aI., 1995a). To identify the Pshl binding domain in 
Cse4, we immunoprecipitated Pshl-FLAG from strains expressing Myc-tagged full-
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length Cse4, NTD-Cse4 or HFD-Cse4. While full length Cse4 and the HFD-Cse4 
associate with Pshl, the NTD-Cse4 does not interact with Pshl (Fig 3.2A). However, I 
reproducibly detected greater levels of full-length Cse4 associating with Pshl compared 
to HFD-Cse4, suggesting that the N-terminus might contribute to the interaction in viva. 
Because the HFD-Cse4 contains the CATD, I asked whether the CATD helps Pshl 
distinguish Csc4 from H3. First, I replaced the CATD in Cse4 with loop 1 and a2 helix 
of H3 to generate Myc_Cse4-CATD (Fig 3.2B, construct 2). The Myc_Cse4-CATD no longer 
immunoprecipitated with Pshl-FLAG, suggesting that the CATD is required for the 
interaction (Fig 3.2C). Second, I tested the interaction of chimeric Myc_H3CATD or Myc-
H3 proteins with Pshl in both the soluble and chromatin-bound fractions (Fig 3.2B 
constructs 3 and 4). Strikingly, the H3CATD protein co-precipitates with Pshl-FLAG in 
the soluble fraction whereas H3 does not (Fig 3.2D). I also detected a robust interaction 
between Pshl and H3CATD in the chromatin fraction, although lower levels of H3 also co-
precipitated with Pshl. This may reveal a decreased affinity of Pshl for H3, or a 
transient interaction in the context of chromatin. Taken together, these data strongly 
suggest that the CATD helps Pshl recognize Cse4. 
The CATD is required/or Pshl-mediated degradation 
Given that the CATD is important for Pshl binding to Cse4, I analyzed the 
stability of the chimeric proteins. First, I analyzed Myc-Cse4-CATD levels in WT and pshl 
mutant cells after repressing transcription and translation. Although Myc_Cse4-CATD is 
quickly degraded, the degradation does not depend on Pshl (Fig 3.3A). This is consistent 
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with Pshl-mediated degradation requiring the CATD. Next, I assayed the stability of the 
Myc_H3CATD construct in a similar experiment and found that the chimeric H3CATD is also 
rapidly degraded (Fig 3.3B). However, in contrast to the Cse4 chimera lacking the 
CATD, the degradation of H3CATD is dependent on Pshl (Fig 3.3C). Taken together, 
these data suggest that the CA TD is a key regulator of Cse4 stability via the Pshl 
ubiquitin ligase. 
Role of the FACT complex in Cse4 regulation 
Pshl was first isolated as an interacting protein of the FACT complex and 
histones (Krogan et ai., 2002). Interestingly, the components of the FACT complex were 
also identified in our Cse416R purification (Ranjitkar et aI., 2010). Given the role of the 
FACT complex in chromatin remodeling, it raised an exciting possibility that FACT may 
somehow be involved in regulating Cse4. To begin to understand this question, I started 
out by addressing the functional relevance of these observed interactions. To test whether 
the interaction between the FACT complex and Cse4 is mediated by Pshl, I performed 
immunoprecipitation with Spt16-FLAG from either wild-type or pshl fj mutants and 
looked at its interaction with Cse4. In wild-type cells, Cse4 co-immunoprecipitates with 
Spt16. In contrast, this interaction is completely abolished in the absence of Pshl, 
indicating that Pshl mediates the association between these two proteins (Fig 3AA). 
Moreover, because Spt16 and Cse4 interaction is intact in a catalytically inactive mutant 
ofPshl, I conclude that the presence ofPshl and not the activity ofPshl is necessary for 
the observed association of Spt16 and Cse4 (data not shown). 
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In order to test if FACT complex has any effect on Cse4 stability, I analyzed 
Myc-Cse4 levels in wild-type and spt 16-13 mutants. As expected, there is a modest effect 
on Cse4 stability in the spt16-13 mutant relative to wild-type cells (Fig 3AB). However, 
because the exact nature of the spt16 allele is not known, this affect on Cse4 stability 
maybe a reflection of the pleiotropic affects of the allele. Therefore, I am currently 
perfonning domain-mapping experiments to delineate the Cse4 and Spt16 interacting 
domains on Pshl, which will allow us to more directly address this question both in vivo 
and in vitro. 
Discussion 
Psh1 is an E3 ligase specific for Cse4 
Although Cse4 and H3 are about 60% identical in the histone fold domain, Pshl 
appears to specifically recognize and degrade Cse4 in vivo. However, in vitro using a 
non-specific E2 enzyme, Pshl is still able to ubiquitinate histone H3 as well as H2A and 
H2B (data not shown). This suggests that additional specificity must exist in vivo that 
allows Pshl to discriminate between Cse4 and other histones. A recent study identified 
Ubc8 as the E2 conjugating enzyme involved with Pshl, however, whether Ubc8 
contributes to specificity remains to be tested in vivo (Hewawasam et aI., 2010) 
The CATD is a key determinant ofCse4 stability 
The CA TD in Cse4 appears to be a key domain that directs Pshl-mediated 
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degradation. A CATD deletion within Cse4 prevents its association with Pshl and 
abolishes Pshl-mediated degradation, and insertion of the CATD is sufficient to mediate 
H3 binding to Pshl. However, I reproducibly detected greater levels of full-length Cse4 
associating with Psh 1 compared to just the HFD of Cse4, suggesting that the N-terminus 
might contribute to the interaction in vivo. Therefore, in the future, it will be important to 
determine whether additional features of Cse4 are involved in mediating the interaction 
with Pshl, as well as to establish whether Psh 1 directly recognizes Cse4 in the context of 
chromatin. 
Mechanism of Cse4 removalfrom ectopic sites by Pshl 
Cse4 and Pshl interact in both the soluble and chromatin fractions, but the precise 
location of the ubiquitination reaction is not known. Based in my data, there are two 
equally likely mechanisms by which Pshl regulates Cse4 localization. 1) Pshl regulates 
the soluble pool of Cse4 thereby indirectly controlling the mis-incorporation rate of Cse4 
at ectopic sites or 2) Pshl may directly recognize the ectopically localized Cse4 on the 
chromatin. The 2nd possibility raises the question of how Psh 1 is able to detect ectopically 
localized Cse4. In addition, the CATD of Cse4 that is recognized by Pshl is buried inside 
the nuc1eosomal strucuture. I speculated that chromatin factors that disassemble 
nucleosomes during chromatin-based processes expose the CATD and allow Pshl to 
target Cse4 for degradation. Consistent with this idea, Cse4 and Psh 1 co-purifY with 
Spt16 and Pob3, components of the budding yeast FACT complex that disassemble and 
reassemble nucleosomes to facilitate transcription and replication (Reinberg and Sims, 
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2006; VanDemark et al., 2006). Pshl mediates the interaction between Cse4 and Spt16, 
suggesting that Pshl could link Cse4 degradation to the FACT complex. In addition, 
mutants in the Spt4 protein that is implicated in nucleosome assembly, nucleosome 
stabilization, and transcription also lead to Cse4 mislocalization to euchromatin (Crotti 
and Basrai, 2004; Hartzog et al., 2002; Swanson and Winston, 1992). A recent study also 
found the SWIISNF chromatin remodeling complex to be involved in removing Cse4 
from ectopic chromosomal regions, specifically at sites normally bound by the SWIISNF 
complex (Gkikopoulos et al., 2011). Hence there appears to be multiple controls over 
Cse4 removal from ectopic sites. 
I propose the following model (Figure 3.5). Cse4 is targeted to centromeres via a 
chaperone-mediated interaction with the CATD, where it becomes protected from 
degradation by either by Scm3 or by kinetochore assembly (Collins et al., 2004b; 
Dunleavy et aI., 2009; Foltz et al., 2009; Hewawasam et al., 2010). Cse4 also localizes to 
euchromatin, especially at sites of high histone turnover (Camahort et al., 2009; 
Lefrancois et al., 2009). Pshl may regulate Cse4 localization by degrading Cse4 that is 
evicted from the chromatin when the CATD is exposed during chromatin-based 
processes. It is also possible that Pshl degrades excess soluble Cse4, thereby indirectly 
controlling its misincorporation rate into the chromatin. Although it is not yet clear 
whether Pshl homologs exist in vertebrates, CATD function is conserved throughout 
eukaryotes (Black et aL, 2007). In addition, depletion of the HJURP chaperone that 
associates in a CATD-dependent manner leads to lower intracellular CENP-A levels 
(Dunleavy et al., 2009) (Shuaib et al., 2010) (Foltz et al., 2009) consistent with the 
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possibility that the proteolytic machinery targets unbound CENP-A for degradation via 
the CATD. In the future, it will be critical to determine whether the mechanisms that 
prevent the non-centromeric accumulation of CENP-A are conserved. It will also be 
interesting to further investigate proteolysis as a mechanism to regulate chromatin 
composition and ultimately maintain epigenetic states in multicellular eukaryotes. 
Experimental Procedures 
Plasmid construction 
CSE4-NTD (residues 1-129) was PCR amplified using primers SB242 and SB245 
and CSE4-HFD (residues 130-229) was PCR amplified using SB243 and SB244 with 
SpeI and SacI sites engineered and cloned into the same sites of PSB209 to create 
pSB378 and pSB379, respectively. pSB1667 and was constructed as follows: The 
H3 CATD construct was obtained from Lars E. Jansen (Black et al., 2007). The Cse4 N-
terminus (residues 1-129) present in the construct was replaced with N-terminus of H3 
(residues 1- 38) using PCR overlay extension. The N-terminus ofH3 was PCR amplified 
with primers SB2653 and SB2654. The HFD domain of the chimeric constructs were 
PCR amplified with primers SB2655 and SB2340. The resulting fragments were 
subsequently used in a PCR reaction with primers SB2653 and SB2340 with SpeI and 
SacI sites engineered to generate fragments containing H3 N-terminus followed by 
H3CATD . The fragments were digested with SpeI and SacI and cloned into the same sites 
ofpGAL-Myc vector (pSB209) to generate pSB1667. HHTl was PCR amplified with SB 
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2771 and 2772 with SpeI and Sac! sites engineered. The resulting fragment was digested 
with the above enzymes and cloned into the same sites in pSB209 to generate pGAL-
Myc-HHT1 (pSB1704). pSB1646 was constructed by PCR overlay extension. First, 
Cse4 residues 1-165 were PCR amplified using primers SB 242 and SB2584, H3 residues 
76-113 were amplified using SB2585 and SB2586 and Cse4 residues 207-230 were 
amplified using SB2587 and SB244. The three PCR fragments described above were 
subsequently used to produce the chimeric fragment, which was in tum amplified using 
SB242 and SB244, digested with SpeI and Sac! and ligated into the same sites of 
pSB209. 
lmmunoprecipitation 
For immunoprecipitations, 50 ml cultures were harvested at midlog phase and 
lysates were prepared as described (Akiyoshi et aI., 2009) except that cell extracts 
wereprepared with glass beads in a beater (Biospec Products, Inc.) for 35 sec, three times, 
with 1 min on ice in between and then centrifuged for 30 minutes. The supernatant was 
incubated with 10 111 of protein G dynabeads (Invitrogen) and either 0.5 111 of M2anti-
Flag (sigma) or 4 111 of A-14 anti-Myc (Santa Cruz Biotechnology, Santa Cruz, CA) 
antibodies for 2 hrs at 40 C. The beads were washed four times with lysis buffer and the 
immunoprecipitates were separated by SDS-P AGE and analyzed by immunoblotting as 
described below. 
For immunoblotting, protein extracts were made and analyzed as described 
(Minshull et aI., 1996). 9E10 anti-Myc antibodies were obtained from Covance 
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(Richmond, CA) and used at a 1: 10,000 dilution. Cse4 antibodies were used at 1 :500 
(Collins et aI., 2004b). Pgk1 antibodies obtained from Invitrogen were used at 1:10,000. 
K4-Me2 H3 antibodies were obtained from Upstate Cell Signaling Solutions (NY, gift 
from Rich Gardner) and used at 1:3000. 
Stability assays 
For all stability assays, cells were grown in 2% raffinose media, a timepoint (-
was taken, and then cultures were induced with 2% galactose for 2.5 hrs at 23°C. 
Timepoints were taken after inhibiting transcription and translation by adding glucose to 
2% and cycloheximide to a final concentration of SOllg/ml respectively. Extracts were 
prepared and protein levels were assayed using Myc antibodies and pgkl as a loading 
control. 
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Fig 3.1 Psh 1 does not associate with H3 in vivo but can ubiquitinate H3 in vitro. 
(A) Anti-Myc-conjugated beads were used to immunoprecipitate Pshl-Myc 
(SBY5364 and SBY8027). The samples were subsequently analyzed by 
immunoblotting with anti-Myc, anti-Cse4 or anti-T7 antibodies. (B) Recombinant H3 
octamers were added to reactions containing ubiquitin-activating enzyme (Ubal), 
ubiquitin-conjugating enzyme (UbcH5a), ubiquitin (Ub), and ATP in the absence (-) 
or presence (+) of GST-Pshl (lanes 3 and 4). GST-Pshl (lane 2) or H3 octamers 
(lane 1) alone were also included in the immunoblot as controls. The blot was probed 
with anti-H3 antibodies. 
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Fig 3.3. The CATD regulates Cse4 stability. 
(A) The stability of Myc-Cse4-CATD was assayed in WT (SBY8700) and pshl.1 
(SBY8760) cells after repressing transcription and translation_ The lysates were 
immublotted with anti-Myc antibodies. Pgkl is a loading control. The (-) timepoint 
indicates samples taken before induction of the protein. (B) The stability of 
Myc-H3CATD (SBY8932) and Myc-H3 (SBY 9134) in WT cells as in (A). The 
lysates were immunoblotted with anti-Myc antibodies. Thbulin is a loading control. 
(C) The stability of Myc-H3CATD was assayed in wild-type (SBY8932) andpshl.1 
(SBY8959) cells as in (A). 
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Fig 3.4. Pshl mediates the interaction between Spt16 and Cse4. 
Pshl mediates the interaction between Sptl6 and Cse4. Spt16-FLAG was immuno-
precipitated from WT (SBY5647) or pshl L\ (SBY 8356) cells and probed for the 
presence ofCse4 with anti-Cse4 antibodies. Cells lacking Spt16-FLAG were used 
as a control (SBY3). The stability ofMyc-Cse4 was assayed in wild-type (SBY3570) 
and spt16-13 (SBY8662) cells after repressing transcription and protein synthesis. 
The blot was probed with anti-Myc. Pgkl is a loading controL 
= kinetochore 
• = Cse4 nucleosome 
/ = ubiquitin chain 
• = Cse4 protein 
(a) 
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./ ~ Degraded by 
.... the proteasome 
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(b) 
,~/ 
' ':';-+ Degraded by 
the proteasome 
Fig 3.5. Pshl-mediated degradation ofCse4. 
Cse4 recognition by its chaperone occurs via the CATD, which targets it to the 
centromere where it is protected from degradation by kinetochore assembly. Pshl 
also recognizes Cse4 via the CATD. Pshl prevents mislocalization ofCse4 in at 
least two possible ways, by (a) recognizing mis-incorporated Cse4 on the chromatin 
and targeting it for degradation, or by (b) by regulating the level of soluble Cse4, 
thereby limiting its misincorporation rate into the euchromatin. The exclusive 
localization ofCse4 to the centromere is therefore maintained by the CATD 
through a combination of targeting Cse4 to the centromere and degrading 
mislocalized Cse4. 
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Table 3.1 Yeast strains used in this study. All strains are isogenic with the W303 
background. Plasmids are indicated in brackets. 
Strain Genotype 
SBY3570 MATa ura3-1 leu2,3-112 his3-11 trp1-1 ade2-1 can1-100 barl-1 
(pSB816, pGAL-13Myc-CSE4, URA3, 2f-l) 
SBY5364 MATa ura3-1Ieu2,3-112 his3-11 trp1-1 ade2-1 can1-100 barl-1 
hht1-hhf1::HYGRO hht2-hhj2::NAT (pSB977, T7-HHT1. 
untaggedHHF1. TRP1, CEN) 
SBY5647 MATa ura3-1Ieu2,3-112 his3-11 trp1-1 ade2-1 can1-100 
bar1:LEU2, SPT16-3FLAG::KAN 
SBY7269 MATa ura3-1Ieu2,3-112 his3-11 trp1-1 ade2-1 can1-100 barl-1 
PSH1-FLAG::TRP1 ura3-1::pGAL-13Myc-CSE4-NTD::URA3 
SBY7270 MATa ura3-1Ieu2,3-112 his3-11 trp1-1 ade2-1 can1-100 bar1-1 
PSH1-FLA G:: TRP 1 ura3-1: :pGAL-13Myc-CSE4-HFD:: URA3 
SBY8027 MATa ura3-11eu2,3-112 his3-11 trp1-1 ade2-1 can1-100 barl-1 
hhtl-hhf1::HYGRO hht2-hhf2::NAT (pSB977, T7-HHT1, 
untagged HHF1, TRP1, CEN) PSHl-13Myc::HIS3 
SBY8356 MATa ura3-1Ieu2,3-112 his3-11 trp1-1 ade2-1 can1-100 
bar1:LEU2, SPT16-3FLAG::KAN, psh1::KAN 
SBY8700 MATa ura3-1Ieu2,3-112 his3-11 trp1-1 ade2-1 can1-100 bar1-1 
pGAL-Myc- Cse4NTD -Cse4 Nhelix_Cse4 alpha] he/ix_H3L1 _ H3alpha2 
helix -Cse4 L2 _CSe4alpha3 helix:: URA3 (pSB 1646) 
SBY8760 
SBY8932 
SBY8959 
SBY8994 
SBY9126 
SBY9133 
SBY9134 
SBY8662 
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MATa ura3-11eu2,3-112 his3-11 trp1-1 ade2-1 can1-100 barJ-1 
psh1 : :KAN pGAL-Myc- Cse4NTD -Cse4 Nhelix -Cse4 alpha] helix _H3Ll_ 
H3 alpha2 helix -Cse4 L2 _CSe4alpha3 helix:: URA3 (pSB 1646) 
MATa ura3-11eu2,3-112 his3-11 trp1-1 ade2-1 can1-100 barJ-1 
PSH1-FLAG::TRP1 ura3-1::pGAL-12Myc-H3NTD -H3 Nhelix_H3 
alphaf helix -Cse4 Ll_ Cse4 alpha2 helix -H3 L2 -H3 alphaJ helix:: URA3 
(pSB1667) 
MATa ura3-1Ieu2,3-112 his3-11 trp1-1 ade2-1 can1-100 barJ-1 
psh1::KAN ura3-1::pGAL-12Myc-H3NTD -H3 Nhelix_H3 alpha] he/ix_ 
Cse4 Ll Cse4 alpha2 helix -H3 L2_H3 alpha3 helix:: URA 3 (pSB1 667) 
MATa ura3-11eu2,3-112 his3-11 trp1-1 ade2-1 can1-100 bar1-1 
ura3-1::pGAL-12Myc-HJIVTD -H3 Nhelix_H3 alphal he/ix_Cse4 Ll Cse4 
alpha2 helix -H3 L2 -H3 alpha3 helix:: URA3(pSB 1667) 
MATa ura3-1Ieu2,3-112 his3-11 trp1-1 ade2-1 can1-100 barJ-1 
PSH1-FLAG:: TRP1 pGAL-Myc- Cse4JvTD -Cse4 Nhelix_Cse4 alpha! 
he/ix_H3LI _ H3 alpha2 helix -Cse4 L2 _CSe4alpha3 helix:: URA 3 (pSB1 646) 
MATa leu2,3-112 his3-11 trp1-1 ade2-1 can1-100 barJ-1 ura3-
1::pGAL-Myc-HHT1::URA3 (pSB1704) 
MATa leu2,3-112 his3-11 trp1-1 ade2-1 can1-100 barJ-1 PSH1-
FLAG::TRP1 ura3-1::pGAL-Myc-HHT1::URA3 (pSB1704) 
MATa ura3-11eu2,3-112 his3-11 trp1-1 ade2-1 can1-100 barl-1 
spt16-J3 (pSB816, pGAL-J3Myc-CSE4, URA3, 2p,) 
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Table 3.2 Plasmids used in this study. 
Plasmid Description 
pSB378 pGAL-13Myc-CSE4-NTD (residues 1-129), URA3 (integrating) 
pSB379 pGAL-13Myc-CSE4-HFD (residues 130- 229), URA3 (integrating) 
pSB893 pGAL-HHTl, TRP (integrating) 
pSB 1646 pGAL-12Myc- Cse4N1D -Cse4 Nhelix -Cse4 alpha1 helix H3 L1 H3 alpha2 helix -Cse4 
L2 _ Cse4 alpha 3 helix, URA 3 (integrating) 
pSB 1667 pGAL-12Myc- H3N1D -H3 Nhelix -H3 alpha1 helix _ Cse4 L1 Cse4 alpha2 helix -H3 L2_ 
H3 alpha 3 helix, URA3 (integrating) 
pSB 1704 pGAL-12Myc-HHT1, URA3 (integrating) 
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CHAPTER 4: 
Conclusions and Perspective 
In this dissertation, I have presented a detailed analysis of the role of the E3 
ubiquitin ligase, Pshl in regulating the centromeric histone H3 variant Cse4. Below, I 
highlight the important findings and speculate on future research. 
Chapter 2: Identification of an E3 ligase that mediates Cse4 degradation and prevents 
ectopic localization ofCse4. 
The centromeric histone H3 variant Cse4 is regulated by ubiquitin-mediated 
proteolysis (Collins et aI., 2004b). In order to identifY molecular machinery involved in 
the process, specifically the E3 ligase that imparts specificity of the substrate, we purified 
a lysine free Cse4 mutant and identified interacting partners by mass spectrometry. I 
identified Pshl an E3 ligase that degrades Cse4. In contrast to wild-type cells, in the 
absence of Pshl, I observed mis-incoproration of overexpressed Cse4 into the 
euchromatin that results in lethality of these cells. I therefore propose that Psh I-mediated 
degradation of Cse4 prevents its misincorporation into eetopic sites, thereby ensuring 
exclusive localization of Cse4 to the centromere. 
Although Pshl and Cse4 can clearly associate with each other independent of the 
centromere, we cannot rule out the possibility of their association at the centromere. 
Consistent with this, a study from another group detected Pshl at the centromere 
(Hewawasam et aI., 2010). However, its centromeric function is not clear. Nevertheless, 
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the previously detected genomic instability in pshl L1 mutant cells is just as consistent 
with a function in preventing ectopic Cse4 localization as in regulating centromere 
function. 
The presence of Psh 1 at the centromere raises several interesting questions. How 
is the centromere bound Cse4 protected from degradation by Psh I? It was recently 
proposed that Scm3, the putative chaperone for Cse4, protects Cse4 from Pshl mediated 
ubiquitination in vitro (Hewawasam et aI., 2010). However, whether this protection is 
relevant to the centromeric pool of Cse4 is not known. In addition, the localization of 
Scm3 to the centromere appears to be cell cycle regulated (personal communication, 
Munira Basrai). Therefore, it will be important in the future to understand whether the 
centromeric localization of Pshl is also cell cycle regulated. It is also possible that the 
activity of Pshl maybe altered by post-translational modifications at the kinetochore or 
by restricting the localization of the E2 conjugating enzyme at the centromere. 
Interestingly, I have observed phosphorylation of Pshl during metaphase, but the 
implication of this modification remains to be investigated (see Appendix B). It will also 
be interesting to investigate whether Pshl has additional roles at the centromere. 
In addition to the centromere, Cse4 also localizes to ectopic sites, although it is 
not completely clear what defines these sites. There is only a 10% correlation between 
ectopic sites and high histone turnover (Gkikopoulos et aI., 2011), therefore additional 
factors must contribute to defining these sites. It will thus be informative to look at what 
happens to the distribution of Cse4 in the absence of proteolysis by Chip-seq experiments 
looking at genome wide Cse4 localization in wild-type and pshl L1 mutants. 
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Chapter 3: The centromere targeting domain of Cse4 regulates its stability and allows 
Pshl to distinguish it from H3. 
I observed that, in contrast to the overexpression of Cse4, overexpression of the 
canonical H3 had no effect on the growth of pshl L1 mutants. This led me to test whether 
Psh I is a specific E3 ligase for Cse4 and if so, to elucidate the mechanism by which it 
discriminates between the two histones. Using domain swap experiments, I found that the 
centromere targeting domain (CATD) of Cse4 is necessary and sufficient for recognition 
by Pshl and Pshl mediated regulation of its stability. In addition, I also found that Pshl 
serves as a physical link between Cse4 and FACT complex, a known chromatin 
remodeler. The increased stability of Cse4 in a mutant of the FACT complex indicate that 
F ACT may cooperate with Pshl to degrade the ectopically localized Cse4. Taken 
together, I propose that FACT destablilizes Cse4 nucleosomes exposing the CATD 
region of Cse4 for recognition by the associated Pshl E3 ubiquitin ligase. 
The underlying mechanism by which Pshl recognizes and degrades Cse4 is not 
yet completely clear. My data is consistent with two possible mechanisms by which Pshl 
prevents euchromatic accumulation of Cse4. Pshl may target the soluble pool of Cse4 
for degradation, thereby keeping the levels low and indirectly controlling the mis-
incorporation rate of Cse4 at ectopic sites. Alternatively, Pshl may directly recognize the 
ectopically localized Cse4 on the chromatin and target it for degradation. In the latter 
scenario, Psh 1 has to be able to access the CATD of Cse4, which is not surface accessible 
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III the context of nucleosoma1 structure (Zhou et aI., 2011). Therefore, FACT may 
provide access for Psh1 to bind to the CATD by destabilizing the nucleosome structure 
while degradation of Cse4 by Psh1 in tum ensures that Cse4 containing nucleosomes are 
not re-assemb1ed by FACT after po1ymerases passage through the chromatin. This model 
also implicates transcription in removing ectopic Cse4, consistent with other studies 
where Cse4 accumulation in the euchromatin has been observed in mutants in the Spt4 
protein that is involved in nucleosome assembly, nucleosome stabilization, and 
transcription (Crotti and Basrai, 2004; Hartzog et aI., 2002; Swanson and Winston, 1992). 
Interestingly, pshl mutants also show negative genetic interactions with genes involved 
in transcription elongation (see appendix A). Therefore, the role of transcription in Cse4 
degradation needs to be more directly tested both in vivo and in vitro. 
Because the available FACT mutants have pleiotropic effects, it will be essential 
to first generate a separation of function allele of FACT subunit genes that specifically 
affect Cse4 degradation. Since Psh1 physically links Cse4 and FACT, a mutant of Pshl 
that does not bind FACT can be used to directly test whether FACT cooperates with Pshl 
in removing the ectopic Cse4 by performing similar experiments that we used for 
analyzing the role of Pshl. Similarly, Pshl mediated in vitro ubiquitination experiments 
using Cse4 nucleosome arrays in the presence and absence of FACT should address 
whether destabilization of Cse4 nucleosomes by FACT is required for Cse4 
ubiquitination by Pshl. This will also provide clues to the relevant form of Cse4 that acts 
as a substrate of Pshl. It will also be important to identify genomic sites where Cse4 
accumulates both in the presence and absence of Pshl as a first step towards directly 
65 
testing the role of transcription. Together, these experiments will give us insight into how 
proteolysis is coupled to transcription to specifically remove ectopic Cse4. 
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Appendix A: 
Alternate pathways of Cse4 degradation 
Cse4 levels are only partially stabilized in pshl Ll mutant cells, indicative of the 
existence of additional pathways that degrade Cse4 that mayor may not be ubiquitin 
dependent. I hypothesized that any such pathway will likely show negative genetic 
interaction with pshl Ll mutants. Given that it is not clear whether there is only one or 
several other pathways involved, we performed an E-map screen with pshl Ll mutant, in 
collaboration with Nevan Krogan (UCSF). E-map (epistatic miniarray profile) is a 
quantitative measurement, which identifies both negative and positive genetic interaction 
between a set of proteins and the severity of such interactions. Our goal was to identify 
and analyze genes that showed the strongest negative interaction with Pshl. The E-map 
screen identified 239 genes that displayed negative interaction and 57 genes with positive 
genetic interaction (Table 1 and 2). I present brief discussions of different classes of 
mutants that were identified in the screen and focus on genes that showed negative 
genetic interactions. 
E3/igases 
The screen identified four genes that have E3 ligase activity or have been shown 
to be involved in ubiquitin-mediated degradation pathway. BreI is an E3 ligase that 
mediates H2B-K123 mono-ubiquitination (Kim and Roeder, 2009). Hex3/Slx5 is a 
Subunit of the Slx5-S1x8 SUMO-targeted ubiquitin ligase (STUbL) complex (Xie et at, 
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2007). Ubx5 and Shpl are Ubx (ubiquitin regulatory X) domain containing proteins that 
interact with Cdc48 to facilitate degradation of ubiquitylated proteins (Schuberth et al., 
2004). In addition, I also compiled a list of known and potential E3 ligases in budding 
yeast (60 genes). In order to determine whether these proteins are involved in Cse4 
degradation, I looked at the effect on viability of these mutants when Cse4 is 
overexpressed either individually or in combination with pshl f1 (data not shown). 
However, none of the E3 ligase mutants tested, including the four identified in the e-map 
screen, displayed reduced viability when Cse4 is overexpressed, suggesting that the 
alternate pathway may be ubiquitin independent (Table 3) . 
Genes involved in transcription elongation 
We also identified several genes implicated in transcription elongation, consistent 
with our hypothesis that transcription plays a role in removal of Cse4 from ectopic sites. 
Two components of the Pafl complex (Cdc73 and Ccr4) and one subunit of the elongator 
complex (Hap2) showed negative genetic interaction with Pshl. Interestingly, Pafl 
complex has been shown to function during elongation in conjuction with Spt4/5 
complex and the FACT complex (Squazzo et al., 2002). Given this, these mutants can be 
used to directly test the role of transcription elongation in Cse4 regulation in combination 
with the studies discussed in chapter 4. 
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Table 1: Genes that show negative genetic interaction with Pshl. Genes are 
listedfrom most negative to least as shown by the scores. 
Gene Score Gene Score Gene Score 
LSMI -19.4 MMS22 -6.1 YILlI0W -4.5 
HAP2 -19.1 TFPl -6.0 PH088 -4.4 
GSH2 -18.5 GGA2 -6.0 BIK! -4.4 
BUB3 -17.1 IES2 -5.9 BUDl3 -4.4 
PAMl7 -16.8 DIA2 -5.9 SSN2 -4.3 
NOP12 -15.4 RPL43A -5.8 MMRI -4.3 
BUBl -14.7 EAPI -5.8 TEXI -4.3 
PEX15 -14.0 RAD52 -5.8 HCR! -4.3 
BIMI -l3.9 RIM21 -5.8 YER156C -4.3 
RTS! -12.8 PDAI -5.7 SUMI -4.2 
BEMI -12.6 MRT4 -5.7 GCN5 -4.1 
HSTl -12.5 ICE2 -5.6 PML39 -4.1 
APM4 -12.1 RRP6 -5.5 PFK2 -4.1 
PRS5 -12.1 VPS24 -5.5 YPR045C -4.1 
PSK2 -11.5 HTZI -5.5 SNF6 -4.1 
MET22 -11.4 RPA34 -5.4 FPSI -4.0 
YLR426W -10.1 REX4 -5.3 PDR16 -4.0 
SILl -10.0 YOR006C -5.2 IKI3 -4.0 
TAT2 -9.7 RPLl9B -5.2 ARCI -4.0 
LGEI -9.1 SICI -5.2 MRCI -4.0 
OPIlO -9.1 RPS16A -5.2 YKE2 -4.0 
CSMI -9.0 MON2 -5.2 RPNIO -3.9 
RPB9 -8.4 PEX17 -5.2 SNX4 -3.9 
HHFI -8.2 UBX5 -5.1 RPS4A -3.9 
STE50 -8.0 YHL029C -5.1 ELP6 -3.9 
MDM38 -7.9 RPS16B -5.0 TYE7 -3.9 
ARP6 -7.9 SAS2 -5.0 CRNI -3.9 
SR07 -7.7 TUB 3 -4.9 GET2 -3.9 
RPPIB -7.5 RTTl09 -4.9 SSFI -3.8 
LSM6 -7.2 IKIl -4.9 KTIl2 -3.8 
INP54 -7.2 VAM6 -4.8 MAK3l -3.8 
YGL046W -7.1 ELP3 -4.8 DEPl -3.8 
RPS28B -6.7 BUD27 -4.8 CTF4 -3.8 
PUF4 -6.6 PPZl -4.7 ADA2 -3.8 
RTGl -6.6 MONI -4.7 PLB3 -3.8 
ASFI -6.6 PMP3 -4.6 HAP4 -3.8 
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SHPl -6.6 TPSl -4.6 YBR238C -3.8 
RP04l -6.3 SWRI -4.6 YARI -3.8 
RPS6A -6.1 ATG17 -4.5 LPDl -3.7 
RPL16B -3.7 EAF6 -3.2 XRS2 -2.8 
YNROO4W -3.7 GIS2 -3.2 CDC26 -2.8 
VPS75 -3.7 COS6 -3.1 MET18 -2.8 
HSC82 -3.7 SAM37 -3.1 CLB3 -2.8 
TC089 -3.7 IWRl -3.1 CDC73 -2.8 
RSA3 -3.6 RMI1 -3.1 PUSl -2.8 
BUD31 -3.6 SGMl -3.1 RPS30A -2.8 
YER064C -3.6 YAL027W -3.0 PEX10 -2.8 
YKR074W -3.6 TOF2 -3.0 POL2 -2.S 
DSS4 -3.6 MKSl -3.0 SIF2 -2.S 
RADl -3.5 MSH2 -3.0 GCR2 -2.8 
YAF9 -3.5 SCS2 -3.0 TOP3 -2.7 
TAF10 -3.5 VPS71 -3.0 SGFll -2.7 
TEPl -3.5 GOSl -3.0 RPS10B -2.7 
BREi -3.5 NGGl -3.0 GDSl -2.7 
PEX32 -3.4 DJPl -3.0 PEX6 -2.7 
LSM7 -3.4 BSTl -3.0 WHI5 -2.7 
SPT21 -3.4 URE2 -2.9 RPL11B -2.7 
RIM10l -3.4 HFIl -2.9 VIKl -2.7 
RPL9A -3.4 KAP120 -2.9 ASM4 -2.7 
SNT2 -3.4 PAC10 -2.9 TIF2 -2.6 
CCR4 -3.4 DOCl -2.9 SIW14 -2.6 
RPB7 -3.4 GIM3 -2.9 VPS41 -2.6 
DBP3 -3.4 IMG2 -2.9 NKP2 -2.6 
PEA2 -3.4 IXRl -2.9 SIN3 -2.6 
AROl -3.4 RPP2B -3.2 GEFl -2.6 
KEMl -3.4 YDR12SW -3.2 ERV46 -2.6 
TRM10 -3,4 BUD21 -3.2 IPKl -2.6 
CBP4 -3.3 TLG2 -3.2 HEX3 -2.6 
LATl -3.3 APE3 -3.1 PLPl -2.6 
RAD27 -3.3 NCS2 -3.1 DBF2 -2.5 
SET2 -3.3 PSY2 -3.1 DPB2 -2.5 
BTSl -3.3 RP021 -3.1 ATG21 -2.5 
RPB3 -3.3 RPL23A -3.1 HTAl -2.5 
KIP3 -3.3 RRPS -2.9 STDl -2.5 
NUP170 -3.3 IST3 -2.9 ELP2 -2.5 
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YPL158C -3.3 MNN10 -2.9 SEYl -2.5 
YEL033W -3.3 RRM3 -2.9 MDM35 -2.5 
RPS29A -3.3 RPL34B -2.8 VAM3 -2.5 
CGRl -3.3 MNSl -2.8 RAD6 -2.5 
RRD2 -3.3 MUS81 -2.8 
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Table 2: Genes that show positive genetic interaction with Pshl. Genes are 
listed from most positive to least as shown by the scores. 
Gene Score Gene Score 
RAD4 12.5 DSE3 2.6 
RSC1 11.4 SLA1 2.6 
YKL023W 8.9 SKI7 2.5 
ASE1 6.7 RLF2 2.5 
DBP7 6.1 
VPS35 3,7 
CKA1 3.6 
PBP1 3.4 
KIN4 3.3 
KEX2 3.2 
FEN1 3.1 
SPT23 3.1 
RBL2 3.0 
BYE1 3.0 
WSC4 3.0 
CDC23 2.9 
HAL5 2.8 
VPS51 2.8 
CHK1 2.8 
CBF1 2.8 
ELA1 2.8 
OAF1 2.8 
RPL19A 2.7 
RBK1 2.7 
YEL007W 2.7 
CDC4 2.7 
IOC3 2.6 
CDC16 2.6 
ERG2 2.6 
MMS4 
LRS4 
YBL036C 
CCW12 
KTR2 
OCA1 
YGR237C 
GPB1 
CHS6 
VPS70 
YHR009C 
RPL8A 
VPS17 
SOY1 
GFD1 
MED4 
RAS2 
UBC1 
PUF6 
MCM21 
TAF13 
YIPS 
PHB2 
YMR102C 
2.5 
2.5 
2.5 
2.5 
2.4 
2.4 
2.3 
2.3 
2.3 
2.3 
2.3 
2.2 
2.2 
2.2 
2.2 
2.2 
2.2 
2.1 
2.1 
2.1 
2.0 
2.0 
2.0 
2,0 
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Table 3: List of E3 liRases tested with overexpression ofCse4 
I AIRI HUL4 . PIB2 I SET3 I UFD4 i 
i i 
i 
ASIl HUL5 . PSP5 i SLXI • VPS8 i 
i i I 
. ASRI ITTl i PXLl SLX8 YBR062C 
. BREI MAG2 PRPI9 I SNT2 YDRI28W 
CST9 MOT2 RAD5 SSM4 YDR266C 
i I 
DMAI NFIl 
i 
RADI6 . STE5 i YER05IW i 
i 
• DMA2 PEP3 RADI8 TFB3 YHLOIOC 
i 
ECM5 I PEP5 RCOI TOMl YIL079C 
i 
FAPI PEX2 i RISI i TULI YJR119C 
FARI PEX2 ROD I UBRI YKROl7C 
I 
HEX3 . PEXIO RKRl UBR2 YLR247C 
I 
HRDI PEX12 SADI UBX5 YMRI87C i 
HRTI PIBI I SANI i UFD2 YOLl38C 
I 
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Appendix B: 
Miscellanous data on Pshl 
r. Observations on cell cycle dependent interaction of Pshl, Cse4 and the FACT 
complex. 
In order to test if Pshl and Cse4 interaction is cell cycle dependent, I performed 
immuno-precipitation experiments from cells arrested at various cell cycle stages. Pshl-
Myc was immuno-precipitated from asynchronous, Gl (a-factor treated), S (HU treated) 
or M (Nocodozole) arrested cells and probed for the presence of Cse4. The interaction 
between Pshl and Cse4 appears to be strongest during mitosis and weak in Gl and S 
phases (Fig. lA), although Pshl levels appear to be lower in G 1. Consistent with Pshl 
mediating the interaction between Cse4 and the FACT complex, the interaction between 
Cse4 and Spt16 also appears to be the strongest in mitosis and S phases and weak in G 1 
(Fig. IB). Interestingly, Pshl appears to be phosphorylated during mitosis, although the 
functional relevance or the kinase involved is not known (Fig. 1 C). It will be interesting 
in the future to test whether phosphorylation of Pshl is involved in regulating the 
interaction between these proteins and also investigate whether the cell cycle dependent 
interaction has relevance to Cse4 degradation or to localization ofPsh1 to the centromere 
or the euchromatin. 
II. Co-overexpression of Mif2 exacerbates the toxicity caused by overexpression of Cse4 
in pshl1\ cells. 
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The severity of the toxicity of Cse4 overexpression in pshl L1 cells is correlated 
with Cse4 protein levels. Lower levels of Cse4 overexpression in pshl L1 cells reduces 
their viability but is not completely lethal. I speculated that other mechanisms that exist 
for Cse4 removal are able to compensate for absence of proteolysis when Cse4 is 
overexpressed at lower levels, perhaps by preventing stable incorporation of Cse4 in the 
euchromatin. We tested if Cse4 can be stabilized when a kinetochore protein is 
simultaneously overexpressed with Cse4. It has been shown that the human Cenp-C and 
Cenp-N proteins bind directly to Cenp-A nucleosomes and are good candidates to 
directly bind and stabilize Cenp-A nucleosomes (Carroll et al., 2010). I therefore chose to 
look at the yeast homolog of Cenp-C, Mif2. We found that co-overexpression of Mif2 
and Cse4 exacerbates the decrease in viability of pshl L1 cells seen when Cse4 alone is 
overexpressed (Fig. 2A). In contrast, there is no effect on the viability of WT cells. 
However, when we looked by chromosome spreads and chromatin fractionation, we did 
not observe any significant increase in the level of Cse4 in the chromatin when Mif2 was 
simultaneously overexpressed (Fig. 2B and data not shown). A more quantitative 
approach such as Chip-seq may be needed to see the difference in Cse4 levels. In vitro 
experiments suggests that CENP-AfH4 tetramers are more readily destabilized relative to 
H3/H4 tetramers (Conde e Silva et aI., 2007). Hence, it would be interesting to test if the 
presence of Mif2, increases the stability of Cse4/H4 tetramers in the assay. Although we 
still do not understand what the observed genetic interaction means, it will be interesting 
in the future to investigate this further. 
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Fig. 1. Cell cycle dependent interaction ofPshl, Cse4 and Spt16. 
(A) Pshl-Myc (SBY 6423) was immunoprecipitated from asynchronous (A), Gl, S or M 
phase arrested cells and probed for the presence of Cse4. (B) Spt16-FLAG (SBY5647) 
was immunoprecipitated as in (A) and probed for the presence of Cse4. (C) Lysates 
from A, G 1, S or M arrested cells were prepared (in lysis buffer) in the presence or 
absence of phosphatase inhibitors. Samples were then incubated at 30 °C for 1 hour 
before adding sample buffer. Blot was probed with anti-Myc antibodies. The 
phosphorylated form ofPshl appears to migrate faster than the unphosphorylated form. 
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Fig. 2: Co-overexpression ofMif2 and Cse4 inpshlA.. 
(A) 5-fold serial dilution of WT+ pGAL Myc-CSE4 (SBY 8783), pshlA. + pGAL Myc-
CSE4 (SBY 8779), WT+ pGAL Myc-MIF2 (SBY 8818), pshlA. + pGAL Myc-MIF2 
(SBY8819), WT + pGAL Myc-CSE4/pGAL Myc-MIF2 (SBY8768) pshlA. + pGAL Myc-
CSE4/pGAL Myc-MIF2 (SBY8769) plated on glucose or galactose. (B) Chromatin 
fractionation of WT or pshlA. cells either overexpressing Cse4 alone or with Mif2. 
Strains used in this experiment are the same as in (A). Blots were probed with anti -Myc 
antibodies. 
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Appendix C: 
Sumoylation of Cse4 
Post-translational modifications of histones play various roles in numerous 
cellular processes. While a large number of post-translational modifications on 
canonical histones have been identified, very few are known to occur on the 
centromeric histone H3 variant, CENP-A to date. 
Phosphorylation and ubiquitination are two modifications known to occur 
on CENP-A. Phosphorylation of CENP-A occurs on Ser7 and Ser50 in humans 
and maize respectively. Human CENP-A is phosphorylated on Ser7 by Aurora A, 
which appears to prime CENP-A for subsequent phosphorylation by Aurora B. 
Phosphorylation of CENP-A appears to be involved in localizing Aurora B to 
inner centromeres and is important for localizing AuroraB, INCENP and PP I from 
chromosomes to the spindle midzone. Because the CENP-A phosphorylation sites 
are present in the highly divergent N-terminal tail, it is not clear whether 
phosphorylation of CENP-A is conserved in other organisms (Kotwaliwale and 
Biggins, 2009) 
Ubiquitination of CENP-A occurs in budding yeast and flies where it leads 
to proteasome mediated degradation of Cse4 and CID respectively. While 
mutation of all the ubiquitin sites on Cse4 still fails to completely stablilize the 
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protein, a recent study identified KI63 of Cse4 to be the preferential lysine on 
Cse4 targeted by the Pshl E3 ubiquitin ligase (Hewawasam et aL, 20lO). In 
addition to K163, K4, K13I, KI55 and K172 were also determined to be 
ubiquitination sites on Cse4 by mass spectrometry. 
Here, I present some preliminary data demonstrating that Cse4 is 
sumoylated in vivo. Interestingly, the sumoylated form of Cse4 appears to be more 
prominent in the absence of ubiquitination by Pshl. 
Sumoylation is a post-translational modification of a protein whereby the 
small ubiqutin-related modifier (SUMO) is conjugated to a substrate via a series of 
enzymatic reactions that are analogous to the ubiquitination reaction. SUMO is 
first processed into its mature form by ubiquitin-like-protein-specific proteases 
(Ulps) and sentrin-specific proteases (SENPs), revealing a carboxy terminal Gly-
Gly motif. The mature SUMO is then activated by SUMO-activating enzyme El 
complex (Uba2/Aosl), followed by transfer onto an E2 conjugating enzyme 
(ubc9) and finally to the substrate either directly or via an E3 ligase (for review, 
see (Gareau and Lima, 20lO). SUMO modification of a substrate can lead to 
diverse cellular fate of the substrate including degradation. SUMO-modified 
substrates can be recognized by SUMO dependent E3 ubiquitin ligases that can 
ubiquitinate the substrate and target it for degradation by the proteasome 
(Uzunova et aL, 2007). 
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Results 
As presented in chapter 2, when Myc-Cse4 is immunoprecipitated from 
wild-type cells, Cse4 ubiquitin conjugates can be detected. In contrast, in the 
absence of Pshl, these conjugates are completely absent. However, when FLAG-
tagged Cse4 (endogeneous) was immuno-precipitated in a similar manner, I 
detected additional bands in the pshl mutant that runs higher than the ubiquitin 
conjugates (see chapter 2 Fig 2.4B). Based on the molecular weight, I speculated 
that it maybe be a sumoylated form of Cse4. In order to verify whether this is 
indeed SUMO conjugate of Cse4, I tested whether this band becomes undetectable 
in the absence of sumoylation. In budding yeast, SUMO is encoded by the 
essential gene SMT3. I immuno-precipitated endogenous FLAG-Cse4 from smt3-
331, a temperature sensitive mutant of SMT3, and in psh1l1smt3-331 double 
mutant, after inactivating smt3 (data not shown). However, the higher molecular 
weight band was still visible leading me to assay the effect on newly synthesized 
Cse4 upon inactivation of SMT3. When pGAL-FLAG-CSE4 was induced in wild-
type, psh 1 11, smt3-331 and psh1 Asmt3-331 cells after inactivating SMT3 and 
immuno-precipitated using anti-FLAG antibodies, the higher molecular weight 
band that is present in psh111 was not detectable in psh1Asmt3-331 double mutant 
indicating that it is a sumoylated form of Cse4. I further verified this using 
antibodies specific to Smt3 (Fig. 1). Furthermore, in smt3-331, the ubiquitin 
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conjugates of Cse4 were still detectable, given that Psh I-dependent ubiquitination 
is still intact in these mutants. Taken together, my data suggests that sumoylation 
is not a priming signal for Pshl-mediated ubiquitination of Cse4 per se, rather 
sumoylation of Cse4 appears to occur in the absence of Pshl-mediated 
ubiquitination. Because, sumoylation was only detected on FLAG-Cse4 but not on 
Myc-Cse4, I also confirmed that it was not occurring on the FLAG tag by 
performing the above experiment with FLAG-Cse416R in which the only lysines 
available for sumoylation is in the FLAG epitope. Higher molecular weight 
species were not detected in either wild-type or the psh 1 mutant suggesting that 
the FLAG epitope is not being sumoylated (Fig. 2) 
Because sumoylation of a protein can lead to its ubiquitation and eventual 
degradation, I next investigated whether sumoylation of Cse4 also leads to its 
degradation. The stability of FLAG-Cse4 was assayed in WT, pshl A, smt3-331 
and pshlAsmt3-331 (data not shown). As expected, Cse4 levels were partially 
stabilized in pshl A mutants compared to the WT. However, Cse4 stability did not 
increase in a double mutant of pshlAsmt3-331 indicating that sumoylation likely 
does not playa role in regulating Ce4 stability. 
The consensus motif for sumoylation is '4'KX(DIE), where '4' is a 
large hydrophobic residue. These residues are known to interact directly with the 
SUMO E2 and hence have a critical role in regulating the stability of the 
interaction of the E2 enzyme and the substrate. Cse4 has a motif in its globular 
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histone fold domain that closely resembles the SUMO consensus motif (MKKD). 
In order to test whether this is the sumoylation site on Cse4, I mutated the two 
lysines within the site (K21SR and K216R) and tested whether this mutant is 
sumoylated in vivo. When FLAG-Cse4 (K2IS/216R) mutant is Immuno-
precipitated from wild-type and pshl,1 background, I was still able to detect 
sumoylated form of the Cse4 (K2lS/2l6R) mutant, indicating that these sites are 
not the SUMO sites on Cse4 or that in the absence of these sites another site is 
utilized (data not shown). Consistent with this, it is known that the SUMO 
consensus motif do not necessarily adhere to strict sequence requirements and 
most validated SUMO consensus sites on a substrate occur in extended loops or 
disordered regions of the substrate outside of its globular domain (Gareau and 
Lima, 2010). Therefore it will be important to identify the sites of sumoylation on 
Cse4 by mass spectrometry in the future to fully understand the role of this 
modification. 
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WB: anti-FLAG exp 
Fig.I. Sumoylation of Cse4. 
.-
j . 
short exp 
IP: anti-FLAG 
WB: anti-Smt3 
WT (SBY8904), pshl!J (SBY8903) , pshl!Jsmt3-331 (SBY9257) and smt3-331 
(SBY9259) cells carrying pGAL-FLAG-CSE4 were grown in lactic acid media. The cells 
were shifted to 36 cC for 1.5 hours and Cse4 expression was induced for 1 hour. FLAG-
Cse4 was immunopreciptated using anti-FLAG antibodies and probed with either anti-
FLAG or anti-Smt3 antibodies (gift from Pam Meluh). 
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FLAG-Cse416R 
IP: anti-FLAG 
WB: anti-FLAG 
Fig. 2. Sumoylation of Cse4 is not occurring on the FLAG epitope. 
WT and pshlL1, cells carrying either pGAL-FLAG-CSE4 (SBY8904 and SBY8903) or 
pCup-FLAG-CSE416R (SBY5442 and SBY9432) were grown in lactic acid media. cells 
Cse4 expression was induced for 1 hour. FLAG-Cse4 was immunopreciptated using anti-
FLAG antibodies. 
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